1
|
Chakraborty C, Lo YH, Bhattacharya M, Das A, Wen ZH. Looking beyond the origin of SARS-CoV-2: Significant strategic aspects during the five-year journey of COVID-19 vaccine development. MOLECULAR THERAPY. NUCLEIC ACIDS 2025; 36:102527. [PMID: 40291378 PMCID: PMC12032352 DOI: 10.1016/j.omtn.2025.102527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 04/30/2025]
Abstract
It has been five years since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and we are also approaching the five-year mark of the COVID-19 pandemic. The vaccine is a significant weapon in combating infectious diseases like SARS-CoV-2. Several vaccines were developed against SARS-CoV-2, and they demonstrated efficacy and safety during these five years. The rapid development of multiple next-generation vaccine candidates in different platforms with very little time is the success story of the vaccine development endeavor. This remarkable success of rapid vaccine development is a new paradigm for fast vaccine development that might help develop infectious diseases and fight against the pandemic. With the completion of five years since the beginning of SARS-CoV-2 origin, we are looking back on the five years and reviewing the milestones, vaccine platforms, animal models, clinical trials, successful collaborations, vaccine safety, real-world effectiveness, and challenges. Lessons learned during these five years will help us respond to public health emergencies and to fight the battle against future pandemics.
Collapse
Affiliation(s)
- Chiranjib Chakraborty
- Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal 700126, India
| | - Yi-Hao Lo
- Department of Family Medicine, Zuoying Armed Forces General Hospital, Kaohsiung 81342, Taiwan
- Department of Nursing, Meiho University, Neipu Township, Pingtung County 91200, Taiwan
| | - Manojit Bhattacharya
- Department of Zoology, Fakir Mohan University, Vyasa Vihar, Balasore, Odisha 756020, India
| | - Arpita Das
- Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal 700126, India
| | - Zhi-Hong Wen
- Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, #70 Lien-Hai Road, Kaohsiung 804201, Taiwan
- National Museum of Marine Biology & Aquarium, # 2 Houwan Road, Checheng, Pingtung 94450, Taiwan
| |
Collapse
|
2
|
Harshaw N, Durante K, Moore K, Bresz K, Campbell A, Perea LL. The Severity of Appendicitis During the COVID-19 Pandemic: A Single Institution Experience. Am Surg 2025; 91:1010-1018. [PMID: 40173088 DOI: 10.1177/00031348251332688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2025]
Abstract
IntroductionThe COVID-19 pandemic led to nationwide stay at home orders, leading to delays in medical care. We sought to identify if the severity of appendicitis changed during the pandemic due to these delays and if there were differences in appendicitis severity in patients with simultaneous COVID-19 infection. We hypothesized that pandemic-related restrictions led to more severe cases of appendicitis.MethodsWe performed a retrospective study (4/2018-4/2022) of all patients ≥ 5y with appendicitis. Patients with a malignant appendiceal specimen were excluded. Clinical outcomes and characteristics were compared in those with appendicitis prior to the COVID-19 (PC) era to those in the COVID-19 (C) era, as well as between COVID-19 positive (C+) and negative (C-) individuals. Univariate analyses were conducted. A P-value <0.05 was considered to be statistically significant.ResultsA total of 1665 patients met inclusion criteria, 806 (48.4%) in PC era, and 859 (51.6%) in C era. Age and gender did not differ from PC era to C era, nor did they differ from the C- group to the C+ group. The C era had significantly higher 30-day readmissions than the PC era (C 6.29% (n = 54) v. PC 2.73% (n = 22), P = 0.001). The C era also had more greater than 30-day readmissions than the PC era (C 3.26% (n = 28) v. PC 1.74% (n = 14), P = 0.048). There was no significant difference in the reason for 30-day or greater than 30-day readmissions for the PC vs C eras. Of the C era, 833 (97.0%) were C- and 26 (3.0%) were C+. Rates of nonoperative management at index admission were not different between groups. The white blood cell (WBC) count was significantly lower in C+, 11.9 (8.55-13.35 IQR), vs C- group, 12.85 (9.9-15.3 IQR), P = 0.0336. There was no significant difference in the severity of appendicitis nor readmission status in C+ vs C- groups during the C era.ConclusionOur data indicates that the PC era had more severe cases of appendicitis as shown by higher rates of perforated and gangrenous appendicitis on pathology reports compared to the C era. Interestingly, readmissions were more prevalent in the C era as opposed to the PC era, which coincided with an increase in complications requiring readmission following laparoscopic appendectomies. In evaluating appendicitis patients according to COVID-19 status, we saw no significant differences in the severity of appendicitis in C- and C+ individuals.
Collapse
Affiliation(s)
- Nathaniel Harshaw
- Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine, Lancaster General Health, Lancaster, PA, USA
| | - Kameron Durante
- Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine, Lancaster General Health, Lancaster, PA, USA
| | - Katherine Moore
- Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine, Lancaster General Health, Lancaster, PA, USA
| | - Kellie Bresz
- Data and Analytics, Penn Medicine, Philadelphia, PA, USA
| | - Alexis Campbell
- Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine, Lancaster General Health, Lancaster, PA, USA
| | - Lindsey L Perea
- Department of Surgery, Division of Trauma and Acute Care Surgery, Penn Medicine, Lancaster General Health, Lancaster, PA, USA
| |
Collapse
|
3
|
Ferreira RS, Mantovani CK, Ferreira ASSBS, Nascimento LDO, Ferrari MDFR, Kawano DF, Massirer KB, Anhê GF, Anholon R, Caricati CP, Ortega LM, Guilbert S, Lambe T, Oliveira-Filho JP, Clemens SAC, Barraviera B. Translational science at the undergraduate level: awakening talents to overcome the valley of death - case report. J Venom Anim Toxins Incl Trop Dis 2025; 31:e20250005. [PMID: 40420995 PMCID: PMC12105585 DOI: 10.1590/1678-9199-jvatitd-2025-0005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2025] [Accepted: 04/09/2025] [Indexed: 05/28/2025] Open
Abstract
Background In the biomedical field, translational science is the process of applying basic scientific knowledge to advance clinical research through the creation of new drugs, devices, medical procedures, preventive measures, and diagnostic kits. The Covid-19 pandemic exposed a shortage of professionals trained in translational research, essential for responding to global demands. To drive advancements, researchers must overcome the 'valley of death', a critical phase in clinical investigation. In response, CEVAP at São Paulo State University (UNESP), Botucatu, Brazil, has developed a strong 'knowledge industry' centered on Translational Science. As part of its research and innovation efforts, CEVAP has developed two biopharmaceuticals, the fibrin sealant and the apilic antivenom, which are currently in the final stage of development. In 2024, CEVAP began the first Brazilian Contract Development and Manufacturing Organization (CDMO) for developing and producing validated and qualified pilot-scale batches to generate clinical trial material. Case Presentation The implementation of the optional undergraduate course in Translational Science marks a crucial step in strengthening the 'knowledge industry'. The program, developed in collaboration with São Paulo's three public universities (USP, UNESP, and UNICAMP), also involves an international partnership with the University of Oxford's Department of Pediatrics and the Oxford Research Group LATAM. The successful launch of this course underscores its importance in interdisciplinary education and institutional collaboration. By bridging gaps between research and application, the program equips professionals to meet the growing demand for expertise in translational science. Given the project's success, it will transition into a one-year 'Qualification in Translational Science', available to students enrolled in São Paulo state universities. Conclusion The preparation of these professionals will be strategic for transforming basic research into products for health, saving lives, and combating future pandemics that will emerge around the world.
Collapse
Affiliation(s)
- Rui Seabra Ferreira
- Center for the Study of Venoms and Venomous Animals (CEVAP), São
Paulo State University (UNESP), Botucatu, SP, Brazil
- Botucatu Medical School, São Paulo State University (UNESP),
Botucatu, SP, Brazil
| | - Cristina Kampus Mantovani
- Center for the Study of Venoms and Venomous Animals (CEVAP), São
Paulo State University (UNESP), Botucatu, SP, Brazil
| | | | | | | | | | - Katlin Brauer Massirer
- Department of Translational Medicine, School of Medical Sciences,
State University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Gabriel Forato Anhê
- Center for Molecular Biology and Genetic Engineering (CBMEG), Center
for Medicinal Chemistry (CQMED), State University of Campinas (UNICAMP), Campinas,
SP, Brazil
| | - Rosley Anholon
- State University of Campinas (UNICAMP), Campinas, SP, Brazil
| | - Celso Pereira Caricati
- Center for the Study of Venoms and Venomous Animals (CEVAP), São
Paulo State University (UNESP), Botucatu, SP, Brazil
| | | | - Sarah Guilbert
- Nuffield Department of Medicine at Oxford University, United
Kingdom
| | - Teresa Lambe
- Department of Pediatrics and Oxford Vaccine Group at the University
of Oxford, United Kingdom
| | - José Paes Oliveira-Filho
- Department of Veterinary Clinical Science, School of Veterinary
Medicine and Animal Science (FMVZ), São Paulo State University (UNESP), Botucatu,
SP, Brazil
| | | | - Benedito Barraviera
- Center for the Study of Venoms and Venomous Animals (CEVAP), São
Paulo State University (UNESP), Botucatu, SP, Brazil
- Botucatu Medical School, São Paulo State University (UNESP),
Botucatu, SP, Brazil
| |
Collapse
|
4
|
Kumar N, Segovia D, Kumar P, Atti HB, Kumar S, Mishra J. Mucosal implications of oral Jak3-targeted drugs in COVID patients. Mol Med 2025; 31:203. [PMID: 40410684 PMCID: PMC12100796 DOI: 10.1186/s10020-025-01260-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2025] [Accepted: 05/12/2025] [Indexed: 05/25/2025] Open
Abstract
The JAK family, particularly JAK3, plays a crucial role in immune signaling and inflammatory responses. Dysregulated JAK3 activation in SARS-CoV-2 infections has been associated with severe inflammation and respiratory complications, making JAK inhibitors a viable therapeutic option. However, their use raises concerns regarding immunosuppression, which could increase susceptibility to secondary infections. While long-term adverse effects are less of a concern in acute COVID-19 treatment, patient selection and monitoring remain critical. Furthermore, adverse effects associated with oral JAK3 inhibitors necessitate the exploration of alternative strategies to optimize therapeutic efficacy while minimizing risks. This review highlights the role of JAK3 in immune and epithelial cells, examines the adverse effects of oral JAK3 inhibitors in COVID-19 and other treatments, and discusses alternative therapeutic strategies for improving patient outcomes.
Collapse
Affiliation(s)
- Narendra Kumar
- ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA.
| | - Daniel Segovia
- ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA
| | - Priyam Kumar
- University of Pennsylvania, Philadelphia, PA, USA
| | - Hima Bindu Atti
- ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA
| | - Soaham Kumar
- Veterans Memorial High School, Corpus Christi, TX, USA
| | - Jayshree Mishra
- ILR-College of Pharmacy, Texas A&M University Health Science Center, Kingsville, TX, USA.
| |
Collapse
|
5
|
Mahmodi MA, Akbari A, Hosseini SMR, Amouzeshi Z. Risk perception of emergency medical technicians in biological disasters: a comparison between COVID-19 and Non-COVID-19 cases. BMC Emerg Med 2025; 25:82. [PMID: 40399782 PMCID: PMC12096615 DOI: 10.1186/s12873-025-01239-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2025] [Accepted: 05/13/2025] [Indexed: 05/23/2025] Open
Abstract
BACKGROUND Emergency medical technicians (EMTs), positioned at the forefront of medical services, are at greater risk of contracting COVID-19 and passing it on to their families and communities than others. Recognizing the risks associated with this disease can play a crucial role in the care and prevention process. Consequently, this study evaluated the level of risk perception (RP) regarding COVID-19 among EMTs and compared it between those who have contracted the disease and those who have not. METHODS This was a cross-sectional descriptive-analytical study conducted in 2021. This study employed simple random sampling to select 200 EMTs affiliated with Birjand University of Medical Sciences. The sample included 100 EMTs who had contracted COVID-19 and 100 who had not. Data were collected through a researcher-designed questionnaire, distributed online via WhatsApp and Telegram groups among the participants. The data were analyzed using SPSS version 16, utilizing descriptive statistical methods (frequency, mean, and standard deviation) along with inferential statistical tests such as independent t-tests, chi-square, and two-way analysis of variance (ANOVA). RESULTS The infected EMTs exhibited a moderate perception of the risk of COVID-19, while the non-infected EMTs reported a high level of RP. The independent t-test confirmed that the mean total score for COVID-19 RP was significantly lower in the infected EMTs compared to the non-infected group (mean RP score: infected 150.82 ± 32.24 vs. non-infected 161.54 ± 22.50, P = 0.007). Additionally, ANOVA revealed that none of the demographic variables individually had a significant impact on the level of COVID-19 RP (P > 0.05). Furthermore, the interaction effect between the demographic variables and the groups was also insignificant (P > 0.05). CONCLUSION EMTs who contracted COVID-19 had a significantly lower RP compared to their non-infected counterparts. This reduced awareness of COVID-19 risks likely contributed to their infection, highlighting the critical role of RP in disease prevention. Targeted educational programs to enhance RP among EMTs could foster stronger adherence to preventive measures, ultimately reducing infection rates during future biological disasters. Therefore, this study not only contributes to expanding existing knowledge in this field but also assists policymakers and health administrators in improving decision-making to strengthen epidemic preparedness.
Collapse
Affiliation(s)
- Mohammad Azim Mahmodi
- Department of Health in Emergencies and Disasters, School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran
- Health in Emergency and Disaster Research Center, Social Health Research Institute, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
| | - Ayob Akbari
- School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran
| | - Seyyed Mohammad Reza Hosseini
- Department of Health in Emergencies and Disasters, School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran
| | - Zahra Amouzeshi
- Department of Nursing, School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran.
| |
Collapse
|
6
|
Hughes TF, Song R, Wang Y, Jacobsen E, Chang CCH, Ganguli M. The impact of the COVID-19 pandemic on symptoms of depression and anxiety among older adults: the MYHAT study. Aging Ment Health 2025:1-9. [PMID: 40372235 DOI: 10.1080/13607863.2025.2505565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Accepted: 05/06/2025] [Indexed: 05/16/2025]
Abstract
OBJECTIVES To identify subgroups of older adults whose mental health was affected by the COVID-19 pandemic. METHODS Interrupted time series (ITS) analyses were used to measure the long-term impact of the COVID-19 pandemic on symptoms of depression (mCES-D) and anxiety (GAD-7) among participants aged 65 years and older (n = 708) from a prospective, longitudinal cohort study. RESULTS Symptoms of depression, but not anxiety, significantly increased at the start of the pandemic, while long-term trends in depression and anxiety during the pandemic were similar to pre-pandemic trends. Participants aged 75 years and older exhibited a more rapid decline in depression symptoms over time than expected after an initial increase. Women experienced a greater immediate increase in anxiety that decreased over time, while men's anxiety increased over time. Cognitively normal participants experienced a greater than expected immediate increase in symptoms of depression that decreased over time, while symptoms were unchanged by the pandemic for those with cognitive impairment. CONCLUSION Despite an initial increase in depression symptoms, the pandemic did not result in elevated symptoms of depression and anxiety long-term. The impact of the pandemic on mental health varied by age, gender, and cognitive status, suggesting some groups may have been more vulnerable than others.
Collapse
Affiliation(s)
- Tiffany F Hughes
- Public Health Program, College of Graduate Studies, Midwestern University, Glendale, AZ, USA
| | - Ruopu Song
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Yueting Wang
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Erin Jacobsen
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
| | - Chung-Chou H Chang
- Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA
| | - Mary Ganguli
- Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
- Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA
| |
Collapse
|
7
|
Sriramaneni N, Botvinov J, Merchant AM. The impact of the COVID-19 pandemic on emergency general surgery outcomes: a retrospective analysis of seven procedures. Updates Surg 2025:10.1007/s13304-025-02225-x. [PMID: 40366625 DOI: 10.1007/s13304-025-02225-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2025] [Accepted: 04/28/2025] [Indexed: 05/15/2025]
Abstract
Current research has examined emergency general surgery (EGS) rates and COVID-19 complications for some procedures, but none have explored complications for all seven EGS procedures before and during the pandemic. Our study addresses this gap, aiming to understand how pandemic-related challenges impact patient outcomes. Utilizing data from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) spanning 2018 to 2021, we conducted a retrospective cohort study with analysis of open and laparoscopic partial colectomy, enterectomy, cholecystectomy, operative management of peptic ulcer disease, adhesiolysis, appendectomy, and laparotomy. Patient outcomes, including 30-day mortality and morbidity, were assessed. The likelihood of complications in EGS has risen compared to pre-COVID levels. Specifically, there is a greater risk of morbidity in open EGS cases intra-COVID compared to laparoscopic, particularly in colectomy and appendectomy procedures. Conversely, laparoscopic procedures have seen a decrease in readmissions, notably in cases involving cholecystectomy and colectomy. The study highlights a rise in complications for EGS intra-COVID, with open procedures demonstrating higher risks than laparoscopic counterparts.
Collapse
Affiliation(s)
| | - Julia Botvinov
- Hackensack Meridian School of Medicine, Nutley, NJ, 07110, USA
| | - Aziz M Merchant
- Department of Surgery, JFK University Medical Center and Hackensack Meridian School of Medicine (HMSOM), 65 James Street, 3rd Floor, Edison, NJ, 08820, USA.
| |
Collapse
|
8
|
Mitchell BJ, Coifman KG. Disgusted, but amused: positive emotion attenuates disgust elicited by film clips. Front Psychol 2025; 16:1565884. [PMID: 40438768 PMCID: PMC12116544 DOI: 10.3389/fpsyg.2025.1565884] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2025] [Accepted: 04/24/2025] [Indexed: 06/01/2025] Open
Abstract
Background Disorders like obsessive-compulsive disorder are associated with heightened disgust. Research suggests that dominant methods for treating such disorders (e.g., exposure therapies) are less effective at targeting disgust. Alternative strategies are needed to enhance treatment effectiveness. Methods In two studies, we investigated positive emotion (elicited via humorous content) for attenuating disgust responses to film clips. In Study 1, n = 174 undergraduates were randomized to view either a humorous, sad, or neutral clip prior to a disgusting clip. In study 2, n = 294 undergraduate participants were randomized to either view two clips with discrete emotional content (purely disgusting and purely amusing) or two mixed emotional clips (disgust mixed with amusement, amusement mixed with disgust). Results Results of Study 1 showed that the humorous clip buffered against ratings of disgust. In Study 2, humorous content reduced reports of disgust. For both studies, the effect of the manipulation was not moderated by clinical characteristics, like disgust proneness, contamination concerns, or depression. Conclusion Findings suggest that positive emotions can alter the appraisal of disgusting content, attenuating feelings of disgust, with potential clinical implications for treatment.
Collapse
|
9
|
Li N, Bai J, Wang L, Chen M, Zhu H, Dong J, Luo M, Zhang H, Xu D, He F, Shi J. Factors influencing the anxiety and depression status in patients undergoing in vitro fertilization-embryo transfer assisted pregnancy. Sci Rep 2025; 15:16303. [PMID: 40348856 PMCID: PMC12065862 DOI: 10.1038/s41598-025-94247-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2024] [Accepted: 03/12/2025] [Indexed: 05/14/2025] Open
Abstract
Women undergoing in vitro fertilization-embryo transfer (IVF-ET) can suffer from anxiety and depression at various levels during the process. This study aimed to assess the anxiety and depression statuses (primary outcome) and influencing factors (secondary outcome) among patients undergoing IVF-ET. A 2019-2020 survey at Northwest Women's and Children's Hospital studied IVF-ET patients, evaluating anxiety and depression with GAD-7 and PHQ-9 alongside demographic data, using logistic regression for influencing factors. Among the 2465 women who undergoing IVF-ET, 27.18% had depression, and 18.46% had anxiety. Bachelors' degree (OR = 0.659, 95%CI: 0.503-0.864), male factor infertility (OR = 0.745, 95%CI: 0.558-0.995), and assessment on the day of starting gonadotropin stimulation (OR = 0.781, 95%CI: 0.626-0.974) were negatively independently associated with depression, while comorbidities (OR = 1.541, 95%CI: 1.281-1.854) and an extended ART strategy (OR = 1.394, 95%CI: 1.162-1.672) were independently associated with depression. High school/technical school education (OR = 0.669, 95%CI: 0.490-0.915) and bachelor's degree (OR = 0.640, 95%CI: 0.472-0.868) were negatively independently associated with anxiety, while an extended ART strategy (OR = 1.476, 95%CI: 1.197-1.820) was independently associated with anxiety. In conclusion, the prevalence of depression and anxiety was high in women undergoing IVF-ET. The study identified factors independently associated with depression and anxiety that could be used to guide the psychological management of women undergoing IVF-ET.
Collapse
Affiliation(s)
- Nan Li
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China
| | - Jun Bai
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China
| | - Lijun Wang
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China
| | - Mei Chen
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China
| | - Hongli Zhu
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China
| | - Jiaojiao Dong
- Department of Gynecology, Shenmu City Hospital, Shenmu, 719300, Shaanxi, China
| | - Mimi Luo
- Department of Obstetrics, Ankang Hospital of Traditional Chinese Medicine, Ankang, 725000, Shaanxi, China
| | - Han Zhang
- Department of Traditional Chinese Medicine, Northwest Women's and Children's Hospital, Xi'an , 710000, Shaanxi, China
| | - Di Xu
- The Fifth Department of Gynecology, the Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shaanxi, China
| | - Fengjie He
- Reproductive Medicine Center, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, 712000, Shannxi, China.
| | - Juanzi Shi
- Center of Reproductive Medicine, Northwest Women and Children's Hospital, Xi'an , 710000, Shaanxi, China.
| |
Collapse
|
10
|
Gebru GN, Henderson AK, Elduma AH, Squire JS, Vandi MA, Moffett D, Foster M. The crucial role the field epidemiology training program played in preparedness and response to the COVID-19 pandemic in Sierra Leone, January 2020 to August 2022. Front Public Health 2025; 13:1566824. [PMID: 40416670 PMCID: PMC12098387 DOI: 10.3389/fpubh.2025.1566824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2025] [Accepted: 04/22/2025] [Indexed: 05/27/2025] Open
Abstract
Background On January 30, 2020, the World Health Organization declared COVID-19 a Public Health Emergency of International Concern (PHIEC). On March 11, 2020, it was characterized as a pandemic, prompting the Government of Sierra Leone to implement response plans. The first case in the country was reported on March 31, 2020. To build resilient public health systems after the Ebola crisis, the Sierra Leone Field Epidemiology Training Program (SLFETP) was launched in 2016 with funding from the U.S. CDC in collaboration with the Ministry of Health and the African Field Epidemiology Network (AFENET). The program started at the FETP Frontline level, a 3-month in-service training program, followed by the FETP Intermediate, a 9-month in-service training program launched in 2017. Both levels adopted the CDC curriculum to the local context. The curriculum consists of classroom modules focusing on surveillance, outbreak investigation, and field projects. The SLFETP graduates and trainees were deployed to assist in COVID-19 response efforts. While reports indicate the SLFETP's contributions to COVID-19 preparedness and response, the specific roles of its graduates and trainees remain undocumented. This paper outlines their crucial involvement during the pandemic in Sierra Leone. Methods We reviewed 12 documents from the SLFETP, including work plans, outbreak investigation reports, and success stories, to assess the FETP's contributions during the COVID-19 pandemic. We interviewed graduates and trainees about their roles and conducted discussions with stakeholders and FETP staff to explore the FETP's role during the pandemic's preparedness and response phases. A thematic analysis was performed. Results The SLFETP played a critical role during the preparedness and response phase of the COVID-19 pandemic. The trainees and graduates enhanced the surveillance system and led key response pillars, such as coordination, surveillance, and quarantine. SLFETP supported districts by building their capacity, especially in the district surveillance pillar, to conduct case investigations, contact tracing, quarantine monitoring, and data management. Conclusions The graduates and trainees reportedly played critical roles in key response pillars across the country in the preparedness and response phase of the COVID-19 pandemic. These gains should be maintained and scaled up to build a strong and resilient public health workforce in Sierra Leone, which is crucial for preparedness and response to future outbreaks.
Collapse
Affiliation(s)
| | - Alden Keith Henderson
- Department of Public Health Sciences, University of Hawaii, Kaneohe, HI, United States
| | | | | | - Mohamed Alex Vandi
- National Public Health Agency, University of Sierra Leone, Freetown, Sierra Leone
| | - Daphane Moffett
- Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Monique Foster
- Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|
11
|
Cavalli M, Eriksson N, Baron T, Yalcinkaya A, Landegren N, Brodin P, Hallberg P, Wadelius M. Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination. NPJ Vaccines 2025; 10:88. [PMID: 40341528 PMCID: PMC12062381 DOI: 10.1038/s41541-025-01139-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2024] [Accepted: 04/15/2025] [Indexed: 05/10/2025] Open
Abstract
This genome-wide association study (GWAS) explores the genetic components of severe adverse events following COVID-19 vaccination, with focus on myocarditis and pericarditis. Three SNPs (rs536572545, rs146289966 and rs142297026) near the SCAF11 gene were linked to pericarditis, while rs570375365 in the LRRC4C gene was associated with myocarditis. These findings suggest that genetic variants may influence inflammation pathways, providing a basis for further investigation into the immunological responses triggered by vaccines.
Collapse
Affiliation(s)
- Marco Cavalli
- Department of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
- Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
| | - Niclas Eriksson
- Department of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Uppsala Clinical Research (UCR) center, Uppsala, Sweden
| | - Tomasz Baron
- Department of Medical Sciences, Cardiology, Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden
| | - Ahmet Yalcinkaya
- Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
- Department of Medical Biochemistry, Hacettepe University Hospital, Ankara, Turkey
| | - Nils Landegren
- Science for Life Laboratory, Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
- Center for Molecular Medicine, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden
| | - Petter Brodin
- Unit for Clinical Pediatrics, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden
- Department of Immunology & Inflammation, Imperial College London, London, United Kingdom
| | - Pär Hallberg
- Department of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Mia Wadelius
- Department of Medical Sciences, Clinical Pharmacogenomics, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
| |
Collapse
|
12
|
Carzaniga T, Calcaterra V, Casiraghi L, Inzani T, Carelli S, Del Castillo G, Cereda D, Zuccotti G, Buscaglia M. Dynamics of Multisystem Inflammatory Syndrome in Children (MIS-C) associated to COVID-19: steady severity despite declining cases and new SARS-CoV-2 variants-a single-center cohort study. Eur J Pediatr 2025; 184:327. [PMID: 40332604 PMCID: PMC12058826 DOI: 10.1007/s00431-025-06153-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2025] [Revised: 04/17/2025] [Accepted: 04/23/2025] [Indexed: 05/08/2025]
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition associated with SARS-CoV-2 infection. The relationship between SARS-CoV-2 variants of concern (VOCs) and the occurrence and severity of MIS-C is unknown. We analyzed the dynamics of MIS-C in the Milan metropolitan area (Italy) during the COVID-19 pandemic, focusing on the epidemiologic trends and disease severity in relation to different VOCs in a single-center study. Fifty-seven MIS-C patients (mean 8.3 ± 3.8 years) admitted to the Pediatric Department of Buzzi Children's Hospital in Milan, Italy, between November 2020 and July 2022, were retrospectively included in the study. The SARS-CoV-2 variant was retrospectively identified from serological fingerprinting (profiles of serum antibodies targeting different variants of SARS-CoV-2 obtained by a label-free microarray biosensor) or by the variant of prevalence. Two main periods of MIS-C case accumulation were observed. The peak of MIS-C cases rate in December 2020 reached 0.6 cases per day, which is nearly double the rate observed in February 2022, despite the larger number of infected subjects. Although the WT variant exhibited a broader range of severity score values, the score distributions for the different variants do not show statistically relevant differences. CONCLUSION The results clearly show a decrease in the incidence of MIS-C in relation to infections, but also support the concept that severity of MIS-C remained essentially unchanged across different virus variants, including Omicron. The course of MIS-C, once initiated, is independent from the characteristics of the triggering variants, although later variants may be considered less likely to induce MIS-C. WHAT IS KNOWN • MIS-C is a rare systemic inflammatory disorder that arises as a post-infectious complication temporally related to SARS-CoV-2 infection. • Fluctuations in MIS-C incidence were observed throughout the pandemic, with the latest variants associated with a lower incidence. WHAT IS NEW • The SARS-CoV-2 variant of infection can be retrospectively confirmed by serum antibody fingerprinting using a label-free microarray biosensor. • Despite the decreasing incidence, MIS-C severity has remained essentially unchanged across SARS-CoV-2 variants.
Collapse
Affiliation(s)
- Thomas Carzaniga
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, 20054, Italy
| | - Valeria Calcaterra
- Department of Pediatrics, Buzzi Children's Hospital, Milano, 20154, Italy
- Pediatrics and Adolescentology Unit, Department of Internal Medicine, University of Pavia, Pavia, 27100, Italy
| | - Luca Casiraghi
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, 20054, Italy
| | - Tommaso Inzani
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, 20054, Italy
| | - Stephana Carelli
- Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi," Department of Biomedical and Clinical Science, University of Milan, Milan, Italy
- Center of Functional Genomics and Rare Diseases, Buzzi Children's Hospital, Milan, 20154, Italy
| | - Gabriele Del Castillo
- Prevention Operational Unit, General Directorate of Welfare, Lombardy Region, Milan, Italy
| | - Danilo Cereda
- Prevention Operational Unit, General Directorate of Welfare, Lombardy Region, Milan, Italy
| | - Gianvincenzo Zuccotti
- Department of Pediatrics, Buzzi Children's Hospital, Milano, 20154, Italy.
- Department of Biomedical and Clinical Sciences, L. Sacco, University of Milan, Milan, 20157, Italy.
| | - Marco Buscaglia
- Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, 20054, Italy.
| |
Collapse
|
13
|
Nyawawa ETM, Mayala HA, Kisenge PR, Byomuganyizi M, Joseph AB, Muhozya AN, Khamis R, Nyawawa EE, Nyangasa JB, Ncheye A, Loth A, Marath A. The Impact of International Missions in Provision of Cardiac Services and Skill Transfer in Respect to Coronary Artery Bypass Grafting at Jakaya Kikwete Cardiac Institute - Tanzania. Braz J Cardiovasc Surg 2025; 40:e20240075. [PMID: 40323999 PMCID: PMC12053801 DOI: 10.21470/1678-9741-2024-0075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 05/11/2024] [Indexed: 05/07/2025] Open
Abstract
OBJECTIVE To assess how efficient the local team attained skills are after several visits made by international missions in respect to number of coronary artery bypass grafting surgery performed and the overall patient outcome. METHODS This was a retrospective study that included all patients who were operated on at the center after being diagnosed with chronic coronary artery disease from May 2016 to December 2023. Patients' demographic data were retrieved from patients' files coupled with theatre record file, entered into a structured questionnaire, and then, in a statistical program. RESULTS A total of 290 patients underwent coronary artery bypass grafting at the center. The international missions performed a total of 159 (54.8%) operations, while the local team operated a total of 131 (45.2%) patients. The study showed significant statistical difference in terms of total operation time (95% confidence interval [CI] = 5.67, 6.01 vs. 95% CI = 6.32, 6.66), aortic cross-clamping time (95% CI = 75.92, 90.00 vs. 95% CI = 111.19, 126.65), and total cardiopulmonary bypass time (95% CI = 115.9, 134.75 vs. 95% CI = 174.52, 201.27) between the international missions and local surgical team, respectively. The mortality rate was higher in patients operated on by the local team (13.7%) than by international missions (8.8%), however there was no statistical difference. CONCLUSION This study has shown the beneficial advantage of international surgical missions to newly established open-heart centers with advanced facilities and skill-deprived team. International surgical missions have greatly contributed to the progression of the center as they oversee and support the programs.
Collapse
Affiliation(s)
| | - Henry A. Mayala
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Peter R. Kisenge
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Moses Byomuganyizi
- Department of Cardiothoracic Surgery, Muhimbili University of
Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania
| | - Alex B. Joseph
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Angela N. Muhozya
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Ramadhan Khamis
- Department of Cardiothoracic Surgery, Muhimbili University of
Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania
| | - Evans E. Nyawawa
- Sekou Toure Regional Referral Hospital, Mwanza, United Republic of
Tanzania
| | - Juma B. Nyangasa
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Adelphina Ncheye
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Alex Loth
- Jakaya Kikwete Cardiac Institute, Dar es Salaam, United Republic of
Tanzania
| | - Aubyn Marath
- Department of Cardiothoracic Surgery, Oregon Health and Science
University, Portland, Oregon, United States of America
| |
Collapse
|
14
|
Dei Cas A, Aldigeri R, Eletto E, Ticinesi A, Nouvenne A, Prati B, Vazzana A, Antonini M, Moretti V, Balestreri E, Spigoni V, Fantuzzi F, Schirò S, Ruffini L, Sverzellati N, Meschi T, Bonadonna R. Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19. Acta Diabetol 2025:10.1007/s00592-025-02507-1. [PMID: 40314776 DOI: 10.1007/s00592-025-02507-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/24/2025] [Accepted: 03/29/2025] [Indexed: 05/03/2025]
Abstract
AIMS Diabetes mellitus (DM) and hyperglycemia are associated with poor outcome(s) in COVID-19 hospitalized patients, but their independent impact on prognosis remains unclear. We aimed to assess the impact of DM and hyperglycemia on COVID-19 outcomes. METHODS Clinical data/records from COVID-19 patients admitted to the Parma University-Hospital (February 23rd to March 31st, 2020) were retrieved and analysed (NCT04550403). Fasting plasma glucose (FPG), inflammatory markers and the main biochemical variables were collected at admission. Patients underwent chest high-resolution CT and arterial blood gas analysis to determine the PaO2/FiO2 ratio (P/F ratio). The primary outcome was a composite of intensive care unit admission and/or death. RESULTS Among 756 subjects, 143 (19%) had DM. These patients were older with higher comorbidity rates. The primary outcome occurred in 61.5% DM patients versus 43.4% without DM (p < 0.001). In multivariable analysis (accuracy UC = 0.93), older age, cardiovascular and kidney diseases, FPG ≥ 126 mg/dl, C-reactive protein, and P/F ratio, but not previous DM, were independent risk indicators. CONCLUSIONS DM indicated poor COVID-19 outcomes, but not when adjusted for other clinical variables/comorbities, suggesting that its impact was mostly driven by concomitant factors. The independent role of fasting hyperglycemia points to the need for further research on its contribution to COVID-19.
Collapse
Affiliation(s)
- Alessandra Dei Cas
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Raffaella Aldigeri
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Elisa Eletto
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
| | - Andrea Ticinesi
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Department of Care Continuity and Multicomplexity, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Antonio Nouvenne
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Department of Care Continuity and Multicomplexity, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Beatrice Prati
- Department of Care Continuity and Multicomplexity, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Angela Vazzana
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
| | - Monica Antonini
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
| | - Valentina Moretti
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
| | - Emanuela Balestreri
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy
| | - Valentina Spigoni
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Federica Fantuzzi
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Silvia Schirò
- Department of Medicine and Surgery, University of Parma, Parma, Italy
| | - Livia Ruffini
- Nuclear Medicine, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Nicola Sverzellati
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Radiological Sciences, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Tiziana Meschi
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Department of Care Continuity and Multicomplexity, Azienda Ospedaliero-Universitaria of Parma, Parma, Italy
| | - Riccardo Bonadonna
- Endocrinology and Metabolic Diseases, Azienda Ospedaliero-Universitaria of Parma, Via Gramsci 14, 43126, Parma, Italy.
- Department of Medicine and Surgery, University of Parma, Parma, Italy.
- Endocrinology, Diabetology and Metabolic Diseases, University of Verona and University Hospital of Verona, Verona, Italy.
| |
Collapse
|
15
|
Prashar N, Mohammed SB, Raja NS, Mohideen HS. Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2. 3 Biotech 2025; 15:116. [PMID: 40191455 PMCID: PMC11971104 DOI: 10.1007/s13205-025-04270-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2025] [Accepted: 03/10/2025] [Indexed: 04/09/2025] Open
Abstract
The COVID-19 pandemic highlighted the potential of peptide-based therapies as an alternative to traditional pharmaceutical treatments for SARS-CoV-2 and its variants. Our review explores the role of therapeutic peptides in modulating immune responses, inhibiting viral entry, and disrupting replication. Despite challenges such as stability, bioavailability, and the rapid mutation of the virus, ongoing research and clinical trials show that peptide-based treatments are increasingly becoming integral to future viral outbreak responses. Advancements in computational modelling methods in combination with artificial intelligence will enable mass screening of therapeutic peptides and thereby, comprehending a peptide repurposing strategy similar to the small molecule repurposing. These findings suggest that peptide-based therapies play a critical and promising role in future pandemic preparedness and outbreak management.
Collapse
Affiliation(s)
- Namrata Prashar
- Bioinformatics and Entomoinformatics Lab, Department of Genetic Engineering, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Chennai, Tamil Nadu 603203 India
| | - Saharuddin Bin Mohammed
- Institute of Biological Sciences, Faculty of Science, Universiti Malaya, 50603 Kuala Lumpur, Malaysia
| | - N. S. Raja
- Deparmtent of Genetic Engineering, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Chennai, Tamil Nadu 603203 India
| | - Habeeb Shaik Mohideen
- Bioinformatics and Entomoinformatics Lab, Department of Genetic Engineering, College of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Chennai, Tamil Nadu 603203 India
| |
Collapse
|
16
|
Subaiea GM, Alkhateeb N, Sahman F, Alsudayri A, Almudayni AM, Alrashidi H, Alshammari AM, Alamri A, Almuntashiri S, Hussain A, Khloofi HA, Anwar S. Charting the COVID-19 vaccination journey in Saudi Arabia: Insights into post-vaccination adverse effects and immunization dynamics. Front Pharmacol 2025; 16:1561410. [PMID: 40356957 PMCID: PMC12066665 DOI: 10.3389/fphar.2025.1561410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2025] [Accepted: 04/02/2025] [Indexed: 05/15/2025] Open
Abstract
Background The current study evaluated the effects of different COVID-19 vaccines on Saudi Arabian residents, focusing on their safety, acceptance, and effectiveness. Gaining a better knowledge of these vaccination results will help develop more successful public health initiatives and increase confidence in vaccination campaigns throughout the Kingdom. Methods A cross-sectional study was conducted with 401 participants from diverse backgrounds, covering different ages, genders, nationalities, weights, and education levels. The survey gathered information about participants' health conditions, their vaccines, side effects, and infection rates before and after vaccination. The data were analyzed to compare vaccine preferences, side effects, and infection trends overtime. Results Sociodemographic-wise, most participants were men (62.84%) and Saudi nationals (96.01%), showing significant differences by gender and nationality (P < 0.001). The largest age group was 21-30 years (45.89%, P < 0.001), with 66.58% being university graduates (P < 0.001). Pfizer/BioNTech was the top choice across all doses, with 83.46% receiving it for the first dose, 78.1% for the second, and 39.28% for the third, reflecting a clear preference over other vaccines (P < 0.001). Pfizer/BioNTech recipients reported side effects after the first dose in 36.53% of cases, but only 1.86% needed medical help. Vaccination significantly reduced infection rates: Pfizer/BioNTech dropped infection rates from 43.18% to 8.33% after the third dose (P < 0.001), while Oxford/AstraZeneca saw rates fall from 12.88% to 0.76% after the third dose, but did not reach significance (P = 0.34). Overall, vaccinated individuals had much lower infection rates (28.17%) than among unvaccinated ones (100%), with a P-value of 0.020. Conclusion Our results concluded that Saudi Arabia's vaccination campaign has proven effective, especially after the second and third doses. Pfizer/BioNTech was the most preferred vaccine, demonstrating strong efficacy and safety, which helped build public confidence. Ongoing monitoring is crucial to maintaining pandemic control, post-marketing and public health strategies.
Collapse
Affiliation(s)
- Gehad M. Subaiea
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | | | - Faisal Sahman
- College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | | | | | | | | | - Abdulwahab Alamri
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | - Sultan Almuntashiri
- Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | - Arshad Hussain
- Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | - Heba Ali Khloofi
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| | - Sirajudheen Anwar
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia
| |
Collapse
|
17
|
Kaawa-Mafigiri D, Muyomba D, Kisakye IS, Semakula D, Sewankambo NK. Research and community engagement during the COVID- 19 pandemic in a resource-limited setting: a mixed methods study with epidemic preparedness implications. BMC Health Serv Res 2025; 25:600. [PMID: 40281635 PMCID: PMC12023498 DOI: 10.1186/s12913-025-12691-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 04/02/2025] [Indexed: 04/29/2025] Open
Abstract
BACKGROUND When WHO declared the SARS-CoV- 2 respiratory virus pandemic in 2020, Uganda was unprepared to prevent and control its spread or manage the COVID- 19 and non-COVID patients. A community trial to assess the efficacy of an intensive community engagement and risk communication (CERC) was contemplated. However, a baseline assessment of the existing CERC status and the challenges of conducting community research in the early months of the pandemic was necessary. METHODS A community baseline qualitative research (in-depth interviews, key informant interviews, focus group discussions, and household conversations) was implemented in 15 parishes (6 and 9 in Kawempe and Nakawa divisions respectively) of Kampala Capital City Authority, Uganda. Qualitative in-depth interviews with 20 household heads (n = 10 in each division), 50 household conversations (n = 25 in each division), and focus group discussions (n = 10, five in each division) were conducted during the pandemic from October 2020 to February 2021. RESULTS Many potential challenges to research involving CERC were identified and were categorized into three main interrelated domains: (a) implementation challenges (b) social, cultural, and political context of the research, and (c) budgetary and funding constraints. CONCLUSIONS The three interrelated challenges identified in this study should be considered in future plans for epidemic and pandemic preparedness. The practical application of conventional concepts like CE, risk communication, qualitative research methods must be re-examined prior to epidemics and pandemics to improve their applicability and responsiveness during complex, dynamic epidemics and pandemics.
Collapse
Affiliation(s)
- David Kaawa-Mafigiri
- Department of Social Work and Social Administration, Makerere University School of Social Sciences, P.O. Box 7062, Kampala, Uganda.
| | - Dickson Muyomba
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | - Irene Sheila Kisakye
- Department of Social Work and Social Administration, Makerere University School of Social Sciences, P.O. Box 7062, Kampala, Uganda
| | - Daniel Semakula
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | - Nelson K Sewankambo
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| |
Collapse
|
18
|
Militaru A, Bulai CA, Ene CV, Popescu RI, Mares C, Balacescu SM, Multescu RD, Georgescu DA, Geavlete PA, Geavlete BF. Changes in Ureteral Stone Treatment During COVID-19: A Single-Center Emergency Department Study. Res Rep Urol 2025; 17:129-138. [PMID: 40297215 PMCID: PMC12036590 DOI: 10.2147/rru.s518331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2025] [Accepted: 04/16/2025] [Indexed: 04/30/2025] Open
Abstract
Purpose We evaluated the hospitalization rate, length of stay, and management of patients with ureteric lithiasis admitted under emergency conditions at a single institution during the COVID-19 pandemic. Patients and Methods A retrospective study was conducted on 219 patients with ureteral lithiasis, divided into pre-COVID-19 (1.10.2019-29.02.2020) and COVID-19 groups (1.10.2020-29.02.2021). The study examined patient and stone characteristics, hospitalization duration, surgical interventions, creatinine levels, and associated urinary tract infections. It also evaluated the complications related to delayed treatment during the pandemic. Results The study found a 73.41% reduction in admissions for obstructive ureteral lithiasis during the COVID-19 pandemic compared to the pre-pandemic period. Notable differences were observed in age (61.5 vs 46 years, p=0.000), gender (p=0.046), stone laterality (p=0.024), location (p=0.002), serum creatinine levels (1.59 vs 1.09 mg/dL, p=0.000), and urine cultures (45.65% vs 23.12%, p=0.002). During the pandemic period, the rate of primary stone extraction procedures decreased (32.6% vs 59%, p<0.001), while operative time (52.89 vs 39.84 minutes, p<0.001) and hospital stay significantly increased (13.09 vs 3.76 days, p<0.001). Conclusion The pandemic resulted in fewer hospitalizations for ureteral lithiasis and an increase in complications, likely due to reduced access to medical care and a greater tendency for upper urinary tract drainage.
Collapse
Affiliation(s)
- Adrian Militaru
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Catalin Andrei Bulai
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Cosmin Victor Ene
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Razvan Ionut Popescu
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Prof. Dr. Th. Burghele” Clinical Hospital, Bucharest, Romania
| | - Cristian Mares
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Stefan Marian Balacescu
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Razvan Dragos Multescu
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Dragos Adrian Georgescu
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Petrisor Aurelian Geavlete
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| | - Bogdan Florin Geavlete
- Department of Urology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
- Department of Urology, “Saint John” Clinical Emergency Hospital, Bucharest, Romania
| |
Collapse
|
19
|
Govender S, Morgan E, Ramahala R, Lobb K, Bishop NT, Tastan Bishop Ö. Transfer learning towards predicting viral missense mutations: A case study on SARS-CoV-2. Comput Struct Biotechnol J 2025; 27:1686-1692. [PMID: 40352476 PMCID: PMC12063013 DOI: 10.1016/j.csbj.2025.04.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2025] [Revised: 04/16/2025] [Accepted: 04/22/2025] [Indexed: 05/14/2025] Open
Abstract
Understanding viral evolution and predicting future mutations are crucial for overcoming drug resistance and developing long-lasting treatments. Previously, we established machine learning (ML) models using dynamic residue network (DRN) metric data and leveraging a vast amount of existing mutation data from the SARS-CoV-2 main protease (Mpro). Here, we sought to assess the generalizability and robustness of the current models across other SARS-CoV-2 proteins. To achieve this, for the first time, we employed a transfer learning (TL) approach, allowing us to determine the extent to which Mpro trained models could be applied to other SARS-CoV-2 proteins. The TL results were highly promising, with artificial neural network (ANN) and random forest (RF) correlation coefficients for Mpro closely matching those of NSP10, NSP16, and PLpro. The ANN |R| value for Mpro was 0.564, while NSP10, NSP16, and PLpro had values of 0.533, 0.527, and 0.464, respectively. Similarly, the RF |R| value for Mpro was 0.673, compared to 0.457, 0.460, and 0.437 for NSP10, NSP16, and PLpro, respectively. Interestingly, we did not observe a strong correlation for the spike (S) protein monomer and its domains. The low p-values that are associated with the correlation |R| values show that the linear correlations between predicted and actual mutation frequencies are statistically significant. This indicates that TL may generalize well across structurally related viral proteins using DRN-derived ML model from Mpro. Overall, we aim to develop a universal ML model for predicting missense mutation frequencies in viral proteins, and this study lays the foundation for that goal.
Collapse
Affiliation(s)
- Shaylyn Govender
- Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda 6139, South Africa
| | - Emily Morgan
- Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda 6139, South Africa
| | - Rabelani Ramahala
- Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda 6139, South Africa
| | - Kevin Lobb
- Department of Chemistry, Rhodes University, Makhanda 6139, South Africa
| | - Nigel T. Bishop
- Department of Pure and Applied Mathematics, Rhodes University, Makhanda 6139, South Africa
- National Institute for Theoretical and Computational Studies (NITheCS), South Africa
| | - Özlem Tastan Bishop
- Research Unit in Bioinformatics (RUBi), Department of Biochemistry, Microbiology and Bioinformatics, Rhodes University, Makhanda 6139, South Africa
- National Institute for Theoretical and Computational Studies (NITheCS), South Africa
| |
Collapse
|
20
|
Privitera GF, Musso N, Micale G, Bonomo C, Alaimo S, Bivona D, Bonacci PG, Scalia G, Stefani S, Pulvirenti A. CovidTGI: A tool to investigate the temporal genetic instability of SARS-CoV-2 variants. iScience 2025; 28:112315. [PMID: 40264800 PMCID: PMC12013479 DOI: 10.1016/j.isci.2025.112315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2024] [Revised: 12/21/2024] [Accepted: 03/25/2025] [Indexed: 04/24/2025] Open
Abstract
The COVID-19 pandemic has underscored the need for fast and accurate epidemiology, particularly due to the high observed mutation frequency in SARS-CoV-2. This study aims to explore the evolution of SARS-CoV-2 through a global analysis. To facilitate a comparative analysis of temporal mutation data, we developed CovidTGI, a Shiny web application. CovidTGI provides insights into observed mutation frequencies and the temporal relationships among mutations across various clades in different geographical regions. Our tool relies on a database that includes 2 million samples obtained from the National Center for Biotechnology Information (NCBI), along with 500 in-house Sicilian samples collected between May 2021 and June 2022. From this smaller group of samples, we identified key variants that are prevalent within a specific clade. Our tool is designed to study the evolution of SARS-CoV-2, which clearly follows a complex trajectory. This complexity highlights the necessity for sophisticated tools like CovidTGI to understand and track the evolution of this virus.
Collapse
Affiliation(s)
- Grete Francesca Privitera
- Department of Clinical and Experimental Medicine, Bioinformatic Unit, University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Nicolò Musso
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), Medical Molecular Microbiology and Antibiotic Resistance Laboratory (MMAR Lab), University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Giovanni Micale
- Department of Clinical and Experimental Medicine, Bioinformatic Unit, University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Carmelo Bonomo
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), Medical Molecular Microbiology and Antibiotic Resistance Laboratory (MMAR Lab), University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Salvatore Alaimo
- Department of Clinical and Experimental Medicine, Bioinformatic Unit, University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Dalida Bivona
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), Medical Molecular Microbiology and Antibiotic Resistance Laboratory (MMAR Lab), University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Paolo Giuseppe Bonacci
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), Medical Molecular Microbiology and Antibiotic Resistance Laboratory (MMAR Lab), University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Guido Scalia
- U.O.C. Laboratory Analysis Unit, A.O.U. ‘Policlinico-Vittorio Emanuele’, University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Stefania Stefani
- Department of Biomedical and Biotechnological Sciences (BIOMETEC), Medical Molecular Microbiology and Antibiotic Resistance Laboratory (MMAR Lab), University of Catania, Via Santa Sofia, 95125 Catania, Italy
| | - Alfredo Pulvirenti
- Department of Clinical and Experimental Medicine, Bioinformatic Unit, University of Catania, Via Santa Sofia, 95125 Catania, Italy
| |
Collapse
|
21
|
Xie Y, Zong Z, Jiang Q, Ke X, Wu Z. Seeking Solutions for Inclusively Economic, Rapid, and Safe Molecular Detection of Respiratory Infectious Diseases: Comprehensive Review from Polymerase Chain Reaction Techniques to Amplification-Free Biosensing. MICROMACHINES 2025; 16:472. [PMID: 40283347 PMCID: PMC12029528 DOI: 10.3390/mi16040472] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/20/2025] [Revised: 04/10/2025] [Accepted: 04/14/2025] [Indexed: 04/29/2025]
Abstract
Frequent outbreaks of respiratory infectious diseases, driven by diverse pathogens, have long posed significant threats to public health, economic productivity, and societal stability. Respiratory infectious diseases are highly contagious, characterized by short incubation periods, diverse symptoms, multiple transmission routes, susceptibility to mutations, and distinct seasonality, contributing to their propensity for outbreaks. The absence of effective antiviral treatments and the heightened vulnerability of individuals with weakened immune systems make them more susceptible to infection, with severe cases potentially leading to complications or death. This situation becomes particularly concerning during peak seasons, such as influenza outbreaks. Therefore, early detection, diagnosis, and treatment are critical, alongside the prevention of cross-infection, ensuring patient safety, and controlling healthcare costs. To address these challenges, this review aims to identify a comprehensive, rapid, safe, and cost-effective diagnostic approach for respiratory infectious diseases. This approach is framed within the existing hierarchical healthcare system, focusing on establishing diagnostic capabilities at hospitals, community, and home levels to effectively tackle the above issues. In addition to PCR and isothermal amplification, the review also explores emerging molecular diagnostic strategies that may better address the evolving needs of respiratory disease diagnostics. A key focus is the transition from amplification technologies to amplification-free biosensing approaches, with particular attention given to their potential for home-based testing. This shift seeks to overcome the limitations of conventional amplification methods, particularly in decentralized and home diagnostics, offering a promising solution to enhance diagnostic speed and safety during outbreaks. In the future, with the integration of AI technologies into molecular amplification technologies, biosensors, and various application levels, the inclusively economic, rapid, and safe respiratory disease diagnosis solutions will be further optimized, and their accessibility will become more widespread.
Collapse
Affiliation(s)
- Yaping Xie
- State Key Laboratory of Intelligent Manufacturing Equipment and Technology, School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; (Y.X.); (Z.Z.); (Q.J.); (X.K.)
- Sansure Biotech Inc., Changsha 410205, China
| | - Zisheng Zong
- State Key Laboratory of Intelligent Manufacturing Equipment and Technology, School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; (Y.X.); (Z.Z.); (Q.J.); (X.K.)
| | - Qin Jiang
- State Key Laboratory of Intelligent Manufacturing Equipment and Technology, School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; (Y.X.); (Z.Z.); (Q.J.); (X.K.)
| | - Xingxing Ke
- State Key Laboratory of Intelligent Manufacturing Equipment and Technology, School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; (Y.X.); (Z.Z.); (Q.J.); (X.K.)
- School of Mechanical Engineering and Automation, Fuzhou University, Fuzhou 350108, China
| | - Zhigang Wu
- State Key Laboratory of Intelligent Manufacturing Equipment and Technology, School of Mechanical Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, China; (Y.X.); (Z.Z.); (Q.J.); (X.K.)
| |
Collapse
|
22
|
Isamail S, Idris IB, Mohd Yusoff H. Obstetric services preparedness among healthcare workers in maternal wards during COVID-19 pandemic. BMC Pregnancy Childbirth 2025; 25:443. [PMID: 40229684 PMCID: PMC11995598 DOI: 10.1186/s12884-025-07474-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2024] [Accepted: 03/13/2025] [Indexed: 04/16/2025] Open
Abstract
BACKGROUND The COVID-19 pandemic has been spreading rapidly since 2019, leading to devastating consequences worldwide, as well as putting healthcare providers at high risk. This study intends to assess the awareness and preparedness activities among maternal healthcare (MHC) workers and to determine factors that lead to obstetric services' preparedness in ten Government Hospitals in Selangor, Malaysia. METHODS A cross-sectional survey was conducted among 409 MHC workers which include doctors, nurses, and midwives in the government hospitals in Selangor, Malaysia between May 2022 till June 2022. Respondents were given validated questionnaires which include socio-demographic background, knowledge, awareness, and attitude as well as the obstetric services' preparedness activities in managing the COVID-19 pandemic. RESULTS Majority of the respondents were nurses/midwives (87.5%), female (98.5%), age 35-45 years old (48.5%), had working experience of more than 5 years (92.7%), had good knowledge and awareness (92.2%) and good obstetric services preparedness (88.3%). However, only about half (54.0%) of them had positive attitude towards COVID-19. When controlling for confounding factors, multivariate analysis showed that working period factor (p < 0.001), knowledge and awareness factor (p < 0.001) and attitude factor (p < 0.001) were significant predictive factors of obstetric services preparedness during the COVID-19 pandemic. CONCLUSIONS Majority of the respondents had good knowledge and awareness, as well as good level of obstetric services preparedness. However, only about half of them had a positive attitude towards COVID-19. The findings in this study revealed that efforts should be made to further increase the knowledge and attitude of MHC workers on COVID-19 and more so to further improve the positivity of their attitude towards this pandemic so that they can provide better obstetric services especially in the current and future pandemics to come.
Collapse
Affiliation(s)
- Sumaiyah Isamail
- Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia
| | - Idayu Badilla Idris
- Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia.
| | - Hanizah Mohd Yusoff
- Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Cheras, Kuala Lumpur, 56000, Malaysia
| |
Collapse
|
23
|
Bleidißel N, Klaas J, Maier M. Macular hole surgery in times of the COVID-19 pandemic. Sci Rep 2025; 15:12737. [PMID: 40222982 PMCID: PMC11994764 DOI: 10.1038/s41598-025-96528-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2024] [Accepted: 03/28/2025] [Indexed: 04/15/2025] Open
Abstract
To assess whether there were any differences in patient presentation, morphological and functional features as well as surgical treatment for full-thickness macular holes (FTMH) during the lockdown periods amidst the COVID-19 pandemic compared to the previous year. A retrospective analysis was conducted on all patients with FTMH who received treatment at a large tertiary center during the lockdown periods from March 16 to June 16, 2020, and December 9, 2020, to June 6, 2021 (35 eyes, mean age 66 years). Corresponding periods from the previous year were chosen as a control group (41 eyes, mean age 71 years). The patients' demographics, preoperative and postoperative best-corrected visual acuity (BCVA), symptom duration, time from presentation to surgical treatment, and surgical technique were determined. The minimal and base diameters of the FTMH were assessed using spectral-domain optical coherence tomography. During the lockdown periods in the COVID-19 pandemic, there were no significant differences in the number of patients, duration of symptoms, time from presentation to surgical treatment, surgical technique, macular hole size, base diameter, closure rate or pre- and postoperative BCVA between the two groups. However, there was a significant increase in the number of patients who presented directly at the clinic on an emergency basis without prior contact with a community-based ophthalmologist. This study suggests that the diagnosis and the provision of timely surgical treatment of FTMH were not affected by the COVID-19 pandemic. However, patients more frequently sought immediate emergency care at the hospital. This could be attributed to challenges in scheduling and obtaining appointments at outpatient clinics during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Nathalie Bleidißel
- Department of Ophthalmology, Klinikum rechts der Isar, Technical University Munich (TUM), Ismaningerstr. 22, 81675, Munich, Germany.
| | - Julian Klaas
- Department of Ophthalmology, University Hospital Munich (LMU), Munich, Germany
| | - Mathias Maier
- Department of Ophthalmology, Klinikum rechts der Isar, Technical University Munich (TUM), Ismaningerstr. 22, 81675, Munich, Germany
| |
Collapse
|
24
|
Song TH, Clemente L, Pan X, Jang J, Santillana M, Lee K. Fine-grained forecasting of COVID-19 trends at the county level in the United States. NPJ Digit Med 2025; 8:204. [PMID: 40216974 PMCID: PMC11992165 DOI: 10.1038/s41746-025-01606-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Accepted: 03/30/2025] [Indexed: 04/14/2025] Open
Abstract
The novel coronavirus (COVID-19) pandemic has had a devastating global impact, profoundly affecting daily life, healthcare systems, and public health infrastructure. Despite the availability of treatments and vaccines, hospitalizations and deaths continue. Real-time surveillance of infection trends supports resource allocation and mitigation strategies, but reliable forecasting remains a challenge. While deep learning has advanced time-series forecasting, its effectiveness relies on large datasets, a significant obstacle given the pandemic's evolving nature. Most models use national or state-level data, limiting both dataset size and the granularity of insights. To address this, we propose the Fine-Grained Infection Forecast Network (FIGI-Net), a stacked bidirectional LSTM structure designed to leverage county-level data to produce daily forecasts up to two weeks in advance. FIGI-Net outperforms existing models, accurately predicting sudden changes such as new outbreaks or peaks, a capability many state-of-the-art models lack. This approach could enhance public health responses and outbreak preparedness.
Collapse
Affiliation(s)
- Tzu-Hsi Song
- Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Leonardo Clemente
- Department of Physics and Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA
| | - Xiang Pan
- Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Junbong Jang
- Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA
| | - Mauricio Santillana
- Department of Physics and Department of Electrical and Computer Engineering, Northeastern University, Boston, MA, 02115, USA.
| | - Kwonmoo Lee
- Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
| |
Collapse
|
25
|
Tuttle JB, Allais C, Allerton CMN, Anderson AS, Arcari JT, Aschenbrenner LM, Avery M, Bellenger J, Berritt S, Boras B, Boscoe BP, Buzon LM, Cardin RD, Carlo AA, Coffman KJ, Dantonio A, Di L, Eng H, Farley KA, Ferre RA, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lachapelle EA, Lanyon LF, Lee J, Lee J, Lian Y, Liu W, Martínez-Alsina LA, Mason SW, Noell S, Novak J, Obach RS, Ogilvie K, O'Neil SV, Ostner G, Owen DR, Patel NC, Pettersson M, Singh RS, Rai DK, Reese MR, Sakata S, Sammons MF, Sathish JG, Sharma R, Steppan CM, Stewart A, Updyke L, Verhoest PR, Wei L, Wright SW, Yang E, Yang Q, Zhu Y. Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease. J Med Chem 2025; 68:7003-7030. [PMID: 40019854 DOI: 10.1021/acs.jmedchem.4c02561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/14/2025]
Abstract
In early 2020, severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infections leading to COVID-19 disease reached a global level leading to the World Health Organization (WHO) declaration of a pandemic. Scientists around the globe rapidly responded to try and discover novel therapeutics and repurpose extant drugs to treat the disease. This work describes the preclinical discovery efforts that led to the invention of PF-07321332 (nirmatrelvir, 14), a potent and orally active inhibitor of the SARS CoV-2 main protease (Mpro) enzyme. At the outset we focused on modifying PF-00835231 (1) discovered in 2004 as a potent inhibitor of the SARS CoV-1 Mpro with poor systemic exposure. Our effort was focused on modifying 1 with the goal of engineering in oral bioavailability by design, while maintaining cellular potency and low metabolic clearance. Modifications of 1 ultimately led to the invention of nirmatrelvir 14, the Mpro inhibitor component in PAXLOVID.
Collapse
Affiliation(s)
- Jamison B Tuttle
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Christophe Allais
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | | | | | - Joel T Arcari
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | | | - Melissa Avery
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Justin Bellenger
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Simon Berritt
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Britton Boras
- Pfizer Research & Development, La Jolla, California 92121, United States
| | - Brian P Boscoe
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Leanne M Buzon
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Rhonda D Cardin
- Pfizer Research & Development, Pearl River, New York 10965, United States
| | - Anthony A Carlo
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Karen J Coffman
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Alyssa Dantonio
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Li Di
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Heather Eng
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Kathleen A Farley
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Rose Ann Ferre
- Pfizer Research & Development, La Jolla, California 92121, United States
| | - Ketan S Gajiwala
- Pfizer Research & Development, La Jolla, California 92121, United States
| | - Scott A Gibson
- Institute of Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322, United States
| | | | - Brett L Hurst
- Institute of Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah 84322, United States
| | - Eugene P Kadar
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Amit S Kalgutkar
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Erik A Lachapelle
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Lorraine F Lanyon
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Jisun Lee
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Jack Lee
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Yajing Lian
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Wei Liu
- Pfizer Research & Development, La Jolla, California 92121, United States
| | | | - Stephen W Mason
- Pfizer Research & Development, Pearl River, New York 10965, United States
| | - Stephen Noell
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Jonathan Novak
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - R Scott Obach
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Kevin Ogilvie
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Steven V O'Neil
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Gregory Ostner
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Dafydd R Owen
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Nandini C Patel
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Martin Pettersson
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Ravi Shankar Singh
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Devendra K Rai
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Matthew R Reese
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Sylvie Sakata
- Pfizer Research & Development, La Jolla, California 92121, United States
| | - Matthew F Sammons
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Jean G Sathish
- Pfizer Research & Development, Pearl River, New York 10965, United States
| | - Raman Sharma
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Claire M Steppan
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Al Stewart
- Pfizer Research & Development, La Jolla, California 92121, United States
| | - Lawrence Updyke
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Patrick R Verhoest
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Liuqing Wei
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Stephen W Wright
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Eddie Yang
- Pfizer Research & Development, Groton, Connecticut 06340, United States
| | - Qingyi Yang
- Pfizer Research & Development, Cambridge, Massachusetts 02139, United States
| | - Yuao Zhu
- Pfizer Research & Development, Pearl River, New York 10965, United States
| |
Collapse
|
26
|
Seong J, Babakulov A, Asilova S, Shakhnoza B, Nodira M, Mirzayev A. Osteonecrosis of the femoral head in post-COVID-19 patients: a retrospective comparative study. J Orthop Surg Res 2025; 20:362. [PMID: 40211352 PMCID: PMC11984230 DOI: 10.1186/s13018-025-05657-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2025] [Accepted: 02/26/2025] [Indexed: 04/14/2025] Open
Abstract
BACKGROUND The COVID-19 pandemic has claimed many lives and continues to impact individuals through post-COVID-19 conditions. Osteonecrosis of the femoral head (ONFH) is increasingly recognized as a major post-COVID-19 complication, yet most studies are limited to case reports and small series. This study aimed to evaluate COVID-19-related factors potentially contributing to ONFH development in post-COVID-19 patients. METHODS A retrospective analysis was conducted on 84 patients with ONFH and a confirmed history of COVID-19. Baseline characteristics were collected, and patients were categorized into the following groups for comparative analysis: (1) vaccinated vs. unvaccinated, (2) unilateral vs. bilateral ONFH, (3) dexamethasone (DEX) and methylprednisolone (MPS) vs. DEX therapy, and (4) Association Research Circulation Osseus (ARCO) stage 2 vs. stage 3. Group differences and associations were analyzed. RESULTS The DEX and MPS-treated group had a greater extent of COVID-19 lung involvement compared to the DEX-treated group (59.2% vs. 36.3%, p = 0.002), as well as longer hospital stays in both general ward (14.2 days vs. 10.6 days, p = 0.018) and ICU (5.4 days vs. 3 days, p = 0.017). The DEX and MPS-treated group also had a longer duration of steroid therapy (19.3 days vs. 12.3 days, p < 0.001) and received higher DEX-equivalent cumulative steroid doses (380 mg vs. 125 mg, p < 0.001). Notably, ONFH symptoms developed earlier in the DEX and MPS-treated group compared to the DEX-treated group (7.5 months vs. 12 months, p = 0.004). Multivariable logistic regression analysis identified cumulative steroid dose as the sole predictor of ONFH severity (OR: 1.015, 95% CI: 1.001-1.028, p = 0.032), with ARCO stage 3 patients receiving higher cumulative steroid doses than stage 2 patients (240 mg vs. 126 mg, p = 0.018). CONCLUSIONS Our study demonstrated that cumulative steroid dose is the primary determinant of ONFH severity in post-COVID-19 patients. Additionally, combined use of corticosteroids may accelerate the onset of ONFH, highlighting the need for cautious steroid management in COVID-19 patients.
Collapse
Affiliation(s)
- Jichang Seong
- School of Medicine, Central Asian University, Tashkent, 111221, Uzbekistan
| | - Abduaziz Babakulov
- Department of Orthopedics and Traumatology, Akfa Medline University Hospital, Tashkent, 100211, Uzbekistan
| | - Saodat Asilova
- Department of Orthopedics and Traumatology, Kimyo University Hospital, Tashkent, 100121, Uzbekistan
| | | | - Makhmudova Nodira
- School of Medicine, Central Asian University, Tashkent, 111221, Uzbekistan
| | - Akbarjon Mirzayev
- Department of Orthopedics and Traumatology, Akfa Medline University Hospital, Tashkent, 100211, Uzbekistan.
| |
Collapse
|
27
|
Fidanoglu V, Saglam M, Pekcetin S, Vardar Yagli N, Yildiz BP, Bayraktaroglu M, Ergun Alis E. Exercise Capacity and Occupational Competence Sequelae in COVID-19 Survivors: A Longitudinal Study. Occup Ther Health Care 2025:1-17. [PMID: 40202293 DOI: 10.1080/07380577.2025.2488124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Accepted: 03/29/2025] [Indexed: 04/10/2025]
Abstract
The Sars-Cov-2 infection disease (COVID-19) causes symptoms during both acute and post-COVID phases. This study assessed exercise capacity and occupational competence of 20 hospitalized COVID-19 patients, at discharge and three months later using the 6-Minute Step Test and Occupational Self-Assessment. Significant differences were found in both exercise capacity and occupational competence scores between discharge and three months later (p < 0.05). However, these measurements were not correlated (p > 0.05). Although patients show improvement after discharge, some symptoms persisted, affecting their exercise, and occupational performance. Further research is needed to explore long-term occupational outcomes of COVID-19 beyond one year.
Collapse
Affiliation(s)
- Vildan Fidanoglu
- Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Haliç University, Istanbul, Turkey
| | - Melda Saglam
- Department of Cardiorespiratory Physiotherapy and Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
| | - Serkan Pekcetin
- Department of Occupational Therapy, Faculty of Gülhane Health Sciences, University of Health Sciences Turkey, Ankara, Turkey
| | - Naciye Vardar Yagli
- Department of Cardiorespiratory Physiotherapy and Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Hacettepe University, Ankara, Turkey
| | - Birsen Pinar Yildiz
- Department of Chest Diseases, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
| | - Mesut Bayraktaroglu
- Department of Chest Diseases, Memorial Bahçelievler Hospital, Istanbul, Turkey
| | - Esra Ergun Alis
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Aydın University VM Medical Park Florya Hospital, Istanbul, Turkey
| |
Collapse
|
28
|
Atarashi Y, Kim J, Irino Y, Amano M, Tsuchiya K, Maeda K, Terada M, Iwamoto N, Shimada S, Mitsuya H, Yanagida M, Takamatsu Y. A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples. Sci Rep 2025; 15:11589. [PMID: 40185856 PMCID: PMC11971398 DOI: 10.1038/s41598-025-94317-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2025] [Accepted: 03/12/2025] [Indexed: 04/07/2025] Open
Abstract
Coronavirus disease-2019 (COVID-19) remains a critical global health concern. We developed a fully automated, high-throughput competition immunoassay to elucidate how epitope recognition on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) correlates with neutralizing activity. Analysis of clinical samples from both SARS-CoV-2-infected and vaccinated individuals revealed that vaccination elicits significantly higher antibody titers across multiple S1 subunit epitopes compared to natural infection. Notably, median antibody levels against the receptor-binding motif (RBM) exceeded 50% in both cohorts, highlighting the RBM as a key target for antibody induction irrespective of immune origin. Furthermore, the strongest correlation with neutralizing activity was observed for antibodies directed against the broader S1 subunit, indicating that epitopes outside the RBM also contribute to neutralization. These findings underscore the importance of both RBM- and non-RBM-directed antibodies in effective immune defense against SARS-CoV-2. Our assay enables large-scale, reliable quantification of neutralizing antibodies and provides critical insights for developing improved diagnostic antigens and vaccine strategies aimed at eliciting robust, multi-epitope immune responses.
Collapse
Affiliation(s)
- Yusuke Atarashi
- Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan
| | - Jeeeun Kim
- Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan
| | - Yasuhiro Irino
- Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan
| | - Masayuki Amano
- Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, 860-8556, Japan
| | - Kiyoto Tsuchiya
- AIDS Clinical Center, Center hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan
| | - Kenji Maeda
- Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan
- Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan, 890-8544
| | - Mari Terada
- Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan
| | - Noriko Iwamoto
- Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan
| | - Shinya Shimada
- Japan Community Healthcare Organization, Kumamoto General Hospital, 866- 8660, Kumamoto, Japan
| | - Hiroaki Mitsuya
- Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan
- Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 20892-1868, Bethesda, MD, USA
- Division of Clinical Sciences, Kumamoto University Hospital, 860-8556, Kumamoto, Japan
| | - Masatoshi Yanagida
- Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan
| | - Yuki Takamatsu
- Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan.
| |
Collapse
|
29
|
Vallibhakara SAO, Piyatham N, Vallibhakara O, Manonai J. Quality of life and the associated factors among postmenopausal women during the COVID-19 pandemic: a cross-sectional study. Arch Womens Ment Health 2025:10.1007/s00737-025-01581-2. [PMID: 40175774 DOI: 10.1007/s00737-025-01581-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Accepted: 03/25/2025] [Indexed: 04/04/2025]
Abstract
PURPOSE To evaluate the quality of life (QOL) of postmenopausal women during the COVID-19 pandemic in Thailand and the associated factors. METHODS A cross-sectional study using a validated Thai version of the WHOQOL-BREF questionnaire to assess QOL was conducted. RESULTS A total of 453 postmenopausal women participated in the study, with a median age of 58 years (ranging from 41 to 65). These women, residing in urban areas of Thailand such as Bangkok, Nonthaburi, Nakhon Pathom, Pathum Thani, Samut Prakan, and Samut Sakhon, completed a survey questionnaire with the assistance of health volunteers during the COVID-19 pandemic, between October 2021 and April 2022. The study revealed that 55.85% of participants reported experiencing poor quality of life (QOL) during the pandemic. Stepwise logistic regression analysis identified several significant associations with QOL. Factors linked to a poorer QOL included lower levels of well-being index (odds ratio [OR] 7.89, 95% confidence interval [CI] 3.16-19.75, P < 0.01), reduced physical activity (OR 2.72, 95% CI 1.62-4.54, P < 0.01), and the severity of menopausal symptoms (OR 1.94, 95% CI 1.42-2.66, P < 0.01). Conversely, higher education (OR 0.28, 95% CI 0.10-0.75, P < 0.01), an earlier onset of menopause (OR 0.55, 95% CI 0.39-0.78, P < 0.01), and occasional social alcohol consumption (OR 0.56, 95% CI 0.33-0.94, P = 0.03) were identified as protective factors for QOL. CONCLUSION These findings highlight the importance of comprehensive menopausal care, addressing both physical and mental well-being, and providing specific care for menopausal symptoms during challenging times of the COVID-19 pandemic.
Collapse
Affiliation(s)
- Sakda Arj-Ong Vallibhakara
- Interdisciplinary Studies and Lifelong Education, Faculty of Public Health, Mahidol University, Bangkok, Thailand
| | - Nichakorn Piyatham
- Department of Obstetrics and Gynecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - Orawin Vallibhakara
- Menopause Unit, Reproductive Endocrinology and Infertility Unit, Department of Obstetrics and Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
| | - Jittima Manonai
- Female Pelvic Medicine and Reconstructive Surgery Unit, Department of Obstetrics & Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| |
Collapse
|
30
|
Carter JY, Khamadi S, Mwangi J, Muhula S, Munene SM, Kanyara L, Kinyua J, Lagat N, Chege J, Oira R, Maiyo A, Stewart R, Postma M, Stekelenburg J, Osur J, van Hulst M. Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study. BMJ Open 2025; 15:e094546. [PMID: 40180388 PMCID: PMC11966967 DOI: 10.1136/bmjopen-2024-094546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2024] [Accepted: 03/07/2025] [Indexed: 04/05/2025] Open
Abstract
OBJECTIVES To assess the prevalence of SARS-CoV-2 antibodies in the residents of Kibera informal settlement in Nairobi, Kenya, before vaccination became widespread, and explore demographic and health-related risk factors for infection. DESIGN A cross-sectional study. SETTING Kibera informal settlement, Nairobi, Kenya. PARTICIPANTS Residents of Kibera informal settlement between October 2019 and August 2021, age 1 year and above who reported no current symptoms of COVID-19. MAIN OUTCOME MEASURES Associations were determined between SARS-CoV-2 positive tests measured with one rapid test and two ELISAs and demographic and health-related factors, using Pearson's χ2 test. Crude OR and adjusted OR were calculated to quantify the strength of associations between variables and seropositive status. RESULTS A total of 438 participants were recruited. Most (79.2%) were age 18-50 years; females (64.2%) exceeded males. More than one-third (39.1%) were unemployed; only 7.4% were in formal, full-time employment. Less than one-quarter (22.1%) self-reported any underlying health conditions. Nearly two-thirds (64.2%) reported symptoms compatible with COVID-19 in the previous 16 months; only one (0.23%) had been hospitalised with a reported negative COVID-19 test. 370 (84.5%) participants tested positive in any of the three tests. There was no significant difference in SARS-CoV-2 seropositivity across age, sex, presence of underlying health conditions, on medication or those ever tested for SARS-CoV-2. Multiple logistic regression analysis showed that COVID-19 symptoms in the previous 16 months were the only significant independent predictor of seropositivity (p=0.0085). CONCLUSION High SARS-CoV-2 exposure with limited morbidity was found in the residents of Kibera informal settlement. The study confirms other reports of high SARS-CoV-2 exposure with limited morbidity in slum communities. Reasons cited include the high infectious disease burden on the African continent, demographic age structure and underreporting due to limited testing and lack of access to healthcare services; genetic factors may also play a role. These factors require further investigation.
Collapse
Affiliation(s)
- Jane Y Carter
- Regional Laboratory Programme, Amref Health Africa, Nairobi, Kenya
| | - Samoel Khamadi
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Joseph Mwangi
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Samuel Muhula
- Monitoring, Evaluation and Learning Department, Amref Health Africa, Nairobi, Kenya
| | - Stephen M Munene
- Regional Laboratory Programme, Amref Health Africa, Nairobi, Kenya
| | - Lucy Kanyara
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Joyceline Kinyua
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Nancy Lagat
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Judy Chege
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Robert Oira
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Alex Maiyo
- Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
| | - Roy Stewart
- Department of Health Sciences, Community and Occupational Medicine, University Medical Centre Groningen, Groningen, The Netherlands
| | - Maarten Postma
- Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
- Department of Economics, Econometrics and Finance, University of Groningen, Faculty of Economics and Business, Groningen, The Netherlands
- Center of Excellence for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia
- Division of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
| | - Jelle Stekelenburg
- Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
- Department of Obstetrics and Gynaecology, Frisius Medical Center Leeuwarden, Leeuwarden, The Netherlands
| | - Joachim Osur
- Office of the Vice Chancellor, Amref International University, Nairobi, Kenya
| | - Marinus van Hulst
- Department of Health Sciences, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
- Department of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands
| |
Collapse
|
31
|
Iordanou C, Turner E. COVID-19 trauma-related stress in young people: do sensory-processing sensitivity, resilience, and life satisfaction play a role? PSYCHOL HEALTH MED 2025; 30:708-722. [PMID: 39679801 DOI: 10.1080/13548506.2024.2439065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 11/27/2024] [Indexed: 12/17/2024]
Abstract
Although COVID-19 was experienced as a traumatic event with long-lasting effects, there is limited data on its traumatic impact in relation to factors that can promote or threaten young people's mental wellbeing. This study investigated the association between sensory-processing sensitivity (SPS), resilience, and life satisfaction with COVID-19 trauma-related stress and whether resilience mediates the relationship between SPS and COVID-19 traumatic stress in a young sample. A total of 441 individuals aged between 16 and 25 years (Mage = 19.26, SD = 1.65) participated in an online survey in the UK between November 2021 and April 2022. We found that SPS was positively correlated, and resilience was negatively correlated with COVID-19 trauma-related stress. Life satisfaction was not significantly related to COVID-19 trauma-related stress. A mediation analysis showed that the relationship between SPS and COVID-19 trauma-related stress was mediated by resilience. Our findings suggest that resilience can be a protective factor against the traumatic effect of COVID-19 in young people, but other factors should also be considered. Our study makes implications about the potential benefits of including resilience in interventions which target young people's mental wellbeing.
Collapse
|
32
|
Sandhya K, Palanisamy PR, Sandhya R. COVID-19 pandemic versus six "A"s of health care services - accessibility, affordability, availability, appropriateness, adequacy, and adherence. J Family Med Prim Care 2025; 14:1320-1324. [PMID: 40396084 PMCID: PMC12088546 DOI: 10.4103/jfmpc.jfmpc_1535_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2024] [Revised: 10/18/2024] [Accepted: 10/26/2024] [Indexed: 05/22/2025] Open
Abstract
Background and Rationale COVID-19 pandemic resulted in a huge setback in health care sector causing morbidity, mortality, lack of manpower, resources, in hospitals. Apart from the direct effects of the disease, the indirect effects include, lockdowns, restriction of movement of people for food, work, medicines, etc. There are certain non-communicable diseases for which lifelong treatment and continuation of care is required and the patients suffering from these diseases were also highly affected during pandemic. The major pillars of health care services are accessibility, affordability, availability appropriateness, adequacy and adherence and it is true that the pandemic had its impact on all these pillars. Methodology A prospective cross sectional study in which 284 patients with NCD answered a questionaire and the responses were analysed. Results There was a lack of accessibility (48%), affordability (42%) availability (54%) appropriateness and 71% of population took self-medication during the period. There was discontinuity in 16% of the population and the reasons for discontinuation include depression, lack of motivation, forgetfulness, financial crisis etc. Conclusion The pandemic exerted a greater influence on saturation of health care services by increasing the mortality, morbidity and as a consequence decreased the health care services to communicable/non-communicable diseases. Our study shows the need and demand for robust health care services during critical times.
Collapse
Affiliation(s)
- Kalidas Sandhya
- Department of Pharmacology, JIPMER, Karaikal, Pondicherry, India
| | | | - R. Sandhya
- Department of Pharmacology, JIPMER, Karaikal, Pondicherry, India
| |
Collapse
|
33
|
Jacobs EJ, Spiker S, Newsome KB, Danielson ML, Bhupalam S, Leeb RT. Mental health in undergraduate students several months into the COVID-19 pandemic compared to before the pandemic. JOURNAL OF AMERICAN COLLEGE HEALTH : J OF ACH 2025; 73:1426-1435. [PMID: 38015158 PMCID: PMC11130070 DOI: 10.1080/07448481.2023.2277193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Revised: 08/23/2023] [Accepted: 10/09/2023] [Indexed: 11/29/2023]
Abstract
OBJECTIVE To compare mental health indicators among undergraduates in Fall 2019, before the COVID-19 pandemic, and Fall 2020, when many students returned to campus amidst restrictions on in-person contact. PARTICIPANTS Analyses included 26,881 undergraduate students, aged 18-24, from 70 U.S. institutions. METHODS Students completed the National College Health Assessment-III survey in Fall 2019 or Fall 2020. RESULTS The prevalences of high stress, loneliness, a low flourishing score, and serious psychological distress increased in 2020 compared to 2019. Serious psychological distress increased substantially in 2020 among students not living with family (adjusted prevalence ratio (aPR)=1.36, 95% CI 1.29-1.45) but not among students living with family (aPR = 1.09, 95% CI 0.95-1.26). CONCLUSIONS These results suggest prevalences of several indicators of poor mental health were elevated among U.S. undergraduates several months into the pandemic. The pandemic may have had greater impact on mental health among students not living with family.
Collapse
Affiliation(s)
- Eric J. Jacobs
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Sable Spiker
- Office of the Associate Director for Policy and Strategy, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Kimberly B. Newsome
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Melissa L. Danielson
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
| | - Sivapriya Bhupalam
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
- Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA
| | - Rebecca T. Leeb
- National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
| |
Collapse
|
34
|
Lue C, Petrie TA, Moore EWG. NCAA international student-athletes' psychological wellbeing during COVID-19: Gender and academic year. JOURNAL OF AMERICAN COLLEGE HEALTH : J OF ACH 2025; 73:1856-1864. [PMID: 39889208 DOI: 10.1080/07448481.2025.2459739] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/19/2024] [Revised: 11/07/2024] [Accepted: 01/21/2025] [Indexed: 02/02/2025]
Abstract
Objective: To examine international student-athletes' (ISAs) rates of depression, perceived stress, problematic drinking, and sleep disturbance. Participants: 509 ISAs (Mage = 20.39 years, women = 63.1%) from over 80 NCAA institutions. Methods: Survey data were collected in April/May 2020. Results: Overall, 27.9% and 9.2% endorsed clinical and high levels of depression and stress, respectively; 2.4% (n = 12) reported severe sleep disturbances and 12.4% (n = 63) problematic drinking. Except problematic drinking, being a woman ISA was associated with significantly higher levels of disturbance. Year in school interacted with gender for perceived stress; men ISAs in their 2nd year or higher reported the lowest levels. Conclusions: Large numbers of ISAs endorsed clinical/severe levels of psychological concerns at onset of COVID-19, likely due to the unique stressors experienced by this international college population. Athletic departments, like universities in general, must provide culturally-sensitive mental health services for their ISAs.
Collapse
Affiliation(s)
- Cachet Lue
- Department of Psychology, University of North Texas, Denton, Texas, USA
| | - Trent A Petrie
- Department of Psychology, University of North Texas, Denton, Texas, USA
| | - E Whitney G Moore
- Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA
| |
Collapse
|
35
|
Xaba N, Qureshi O, Pasha A, Malik A, Hoppe A, Tun ZM, Fynn N, Sibeko G, Khowaja S, Khan AJ. Sociodemographic and Psychosocial Factors Influencing COVID-19 Testing Uptake: Insights from Urban and Rural Communities in South Africa. Am J Trop Med Hyg 2025; 112:37-45. [PMID: 39903929 PMCID: PMC11965710 DOI: 10.4269/ajtmh.23-0810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2023] [Accepted: 11/20/2024] [Indexed: 02/06/2025] Open
Abstract
Access, demand, and acceptance of coronavirus disease 2019 (COVID-19) testing have varied globally. This study explored the sociodemographic and psychosocial risk factors that contribute to the uptake of COVID-19 testing in community settings in South Africa. This paper presents a cross-sectional secondary analysis using data from a cluster randomized controlled trial and a nested perception survey of COVID-19 antigen testing in communities located in urban (eThekwini, KwaZulu-Natal) and rural settings (Worcester, Eastern Cape) in South Africa. Individuals who were reluctant to get tested participated in the perception survey. Data were analyzed using descriptive statistics and multivariable logistic regression to assess linear associations and estimate adjusted odds ratios (ORs). The analysis was conducted on 3,074 individuals, of whom 2,509 (81.6%) provided consent for COVID-19 testing. Among those, 2,505 (81.5%) tested negative, and 4 (0.1%) tested positive for COVID-19. The mean age of participants was 38 (SD = 14.61), and 57% were male. Females (OR: 1.27; 95% CI = 1-1.6), individuals older than 56 years (OR: 1.95; 95% CI = 1.24-3.07), and those who were vaccinated (OR: 1.99; 95% CI = 1.53-2.60) were more likely to consent. Individuals who had previously tested positive for severe acute respiratory syndrome coronavirus 2 were less likely to consent to testing (OR: 0.64; 95% CI = 0.11-0.46). No link was found between depression, anxiety, substance use, and willingness to undergo COVID-19 testing. A perceptions survey involving 704 participants, which explored factors influencing testing willingness, found that older adults, and urban populations were less likely to undergo COVID-19 testing. Targeted health campaigns may improve testing rates. Larger-scale implementation research is required to explore best practices for improving testing rates and confidence in population-level detection within South Africa.
Collapse
Affiliation(s)
- Nokhanyo Xaba
- Interactive Research & Development (IRD), South Africa, Durban, South Africa
| | - Onaiza Qureshi
- Interactive Research & Development (IRD), Pakistan, Karachi, Pakistan
| | - Aneeta Pasha
- Interactive Research & Development (IRD), South Africa, Durban, South Africa
- Interactive Research & Development (IRD) Global, Singapore
| | - Amyn Malik
- Interactive Research & Development (IRD) Global, Singapore
| | - Anne Hoppe
- FIND, Geneva, Switzerland
- Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland
| | - Zaw Myo Tun
- Interactive Research & Development (IRD) Global, Singapore
| | - National Fynn
- Interactive Research & Development (IRD), South Africa, Durban, South Africa
| | - Goodman Sibeko
- Department of Psychiatry, University of Cape Town, Cape Town, South Africa
| | - Saira Khowaja
- Interactive Research & Development (IRD) Global, Singapore
| | | |
Collapse
|
36
|
Victorin D, Bergquist H, Hafsten L, Nihlén Å, Lindell E. Low Molecular Weight Heparin Dosing in Relation to Postoperative Bleeding After Tracheotomy in Patients Infected With SARS-CoV-2-A Descriptive Study. Laryngoscope Investig Otolaryngol 2025; 10:e70122. [PMID: 40177253 PMCID: PMC11963079 DOI: 10.1002/lio2.70122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2024] [Revised: 01/02/2025] [Accepted: 02/02/2025] [Indexed: 04/05/2025] Open
Abstract
Objective The aim of this study was to analyze whether patients with SARS-CoV-2 who received surgical tracheotomy had a lower incidence of postoperative bleeding if their LMWH was postponed or canceled on the day of surgery. Methods Patients with SARS-CoV-2 admitted to the intensive care units who underwent surgical tracheotomy were assessed retrospectively through their medical records. Data on comorbidity, LMWH dose, and timing were collected. Bleedings < 72 h post surgery were noted as stomal or airway bleedings. Results All 101 patients included were on LMWH. Twenty-two patients had no change of dose of LMWH, 24 patients had their dose of LMWH postponed to post surgery, and 50 patients had their dose reduced to only the evening dose on the day of surgery. Twenty-six patients had a stomal bleeding, one patient had an airway bleeding, and four patients had both stomal and airway bleedings. No significant difference in the incidence of bleeding was identified between various groups of different LMWH doses or timing, reduced dose versus no change of dose, OR 1.29 (95% CI 0.42-3.92). Postponed dose versus no change of dose of LMWH, OR 1.03 (95% CI 0.28-3.75). Increasing age was correlated to a higher risk of bleeding post-surgery by an OR of 1.64 (95% CI 1.06-2.54, p = 0.026 for every 10 years added). No fatal bleeding related to surgical tracheotomy was observed. Conclusion Decreased doses of LMWH on the day of surgery were not associated with a risk reduction for post-surgical bleeding in patients with SARS-CoV-2 who received tracheotomy. Increasing age was a risk factor for post-surgical bleeding. Level of Evidence Retrospective, level 3.
Collapse
Affiliation(s)
- David Victorin
- Department of OtorhinolaryngologyRegion Västra Götaland, Södra Älvsborg HospitalBoråsSweden
- Department of Research, Education and InnovationRegion Västra Götaland, Södra Älvsborg HospitalBoråsSweden
| | - Henrik Bergquist
- Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical SciencesSahlgrenska Academy, University of GothenburgGothenburgSweden
- Department of OtorhinolaryngologyRegion Västra Götaland, Sahlgrenska University HospitalGothenburgSweden
| | - Louise Hafsten
- Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical SciencesSahlgrenska Academy, University of GothenburgGothenburgSweden
| | - Åsa Nihlén
- Department of OtorhinolaryngologyRegion Västra Götaland, Södra Älvsborg HospitalBoråsSweden
| | - Ellen Lindell
- Department of OtorhinolaryngologyRegion Västra Götaland, Södra Älvsborg HospitalBoråsSweden
- Department of Otorhinolaryngology, Head and Neck Surgery, Institute of Clinical SciencesSahlgrenska Academy, University of GothenburgGothenburgSweden
| |
Collapse
|
37
|
Murphy B, Rohrbeck CA, Wirtz PW, Hoffert F, DeArcangelis N. Optimism and emergency preparedness self-efficacy: Moderators of the relationship between perceived threat of disasters and COVID-19 anxiety symptoms. JOURNAL OF AMERICAN COLLEGE HEALTH : J OF ACH 2025; 73:1847-1855. [PMID: 39908328 DOI: 10.1080/07448481.2025.2455629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Revised: 11/02/2024] [Accepted: 01/13/2025] [Indexed: 02/07/2025]
Abstract
Objectives: Despite research showing the impact of the threat of COVID-19 on mental health, scholars have failed to examine the relationship between perceived disaster threat and COVID-19 anxiety. Factors that buffer that positive relationship (e.g., optimism and emergency preparedness self-efficacy or EPSE) are also understudied. Thus, we examined the relationship between the perceived threat of disasters and COVID-19-related anxiety, as well as potential moderating factors of this relationship, including optimism and EPSE. Participants and methods: Participants were a representative sample of U.S. college students (N = 392) recruited through Prolific.co who completed measures in an online Qualtrics survey. Results: Both optimism and EPSE were significant moderators of the relationship between perceived threat and symptoms of anxiety related to COVID-19. When both moderators were included in a double moderation model analysis, only EPSE remained a significant moderator. Conclusions: These findings reflect the importance of cultivating protective psychological resources to protect college students' well-being during disasters.
Collapse
Affiliation(s)
- Blakely Murphy
- Department of Psychological and Brain Sciences, George Washington University, Washington, District of Columbia, USA
| | - Cynthia A Rohrbeck
- Department of Psychological and Brain Sciences, George Washington University, Washington, District of Columbia, USA
| | - Philip W Wirtz
- Department of Psychological and Brain Sciences, George Washington University, Washington, District of Columbia, USA
- Department of Decision Sciences, George Washington University, Washington, District of Columbia, USA
| | - Felicity Hoffert
- Department of Psychology, La Salle University, Philadelphia, Pennsylvania, USA
| | - Nicolas DeArcangelis
- Department of Psychological and Brain Sciences, George Washington University, Washington, District of Columbia, USA
| |
Collapse
|
38
|
K S, Manjini Jayaram K, Thabah MM. COVID-19 Vaccine Acceptance, Knowledge, Attitudes and Socio-Demographic Factors of General Population: A Mixed-Methods Study. Cureus 2025; 17:e82867. [PMID: 40416204 PMCID: PMC12102516 DOI: 10.7759/cureus.82867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/22/2025] [Indexed: 05/27/2025] Open
Abstract
INTRODUCTION The COVID-19 vaccine offers the most effective means to control the pandemic. Understanding vaccine acceptance is crucial due to high levels of vaccine hesitancy and relatively low vaccination coverage. The aim of this study is to assess the general population's knowledge and attitude toward COVID-19 vaccination. METHODS An explanatory mixed-method approach was used among the general population attending outpatient services at a tertiary care hospital. A total of 369 eligible individuals encountered during the data collection period were included. Their knowledge and attitude regarding COVID-19 vaccination were assessed using a self-structured questionnaire. Additionally, in-depth interviews were conducted to explore reasons for vaccine hesitancy. Statistical analyses included mean with standard deviation (SD) or median with interquartile range (IQR), and correlation coefficients. RESULTS Among the 369 participants, 226 (61.2%) demonstrated moderate knowledge, while 241 (65.3%) exhibited a favorable attitude toward the COVID-19 vaccine. A positive correlation between knowledge and attitude was observed (r = 0.114, p = 0.029). Participants perceived the vaccine as a means to prevent infection, build immunity, and ensure safety. Hesitancy stemmed from concerns about side effects, age, health issues, fear of needles, lack of awareness, and media influence. CONCLUSION The primary factor driving vaccine hesitancy was fear of adverse effects following vaccination. Misinformation and fear are significant barriers to achieving global vaccination goals, requiring targeted interventions to enhance awareness and acceptance.
Collapse
Affiliation(s)
- Sindhuja K
- Medical Surgical Nursing, College of Nursing, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND
| | - Kumari Manjini Jayaram
- Nursing, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND
| | - Molly Mary Thabah
- Internal Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, IND
| |
Collapse
|
39
|
Alibudbud R. The COVID-19 pandemic and the worldwide online interest in telepsychiatry: an infodemiological study from 2004 to 2022. Front Digit Health 2025; 7:1425684. [PMID: 40236606 PMCID: PMC11998030 DOI: 10.3389/fdgth.2025.1425684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Accepted: 03/18/2025] [Indexed: 04/17/2025] Open
Abstract
Introduction Studies call for the further assessment and understanding of public interests and concerns about telepsychiatry, especially during the COVID-19 pandemic. Since telepsychiatry services are accessed through the Internet, this study analyzed online searches and queries to determine telepsychiatry-related interests and concerns over time. The findings can inform the development and customization of online telepsychiatry resources and services, enabling a more effective response to public needs. Materials and methods This study determined public concerns and interests in telepsychiatry using data from Google Trends and Wikipedia from 2004 to 2022. These platforms were selected for their large global market share. After describing the data, bootstrap for independent sample tests of search volumes and Wikipedia page views before and during the COVID-19 pandemic. Results The highest interest in telepsychiatry was observed in high-income countries. Search volumes for telepsychiatry increased, while Wikipedia page views decreased during the COVID-19 pandemic. The top and rising queries that can be incorporated into telepsychiatry websites include telepsychiatry concepts, jobs, services, costs, and locations. Discussion The findings support that the use of the Internet for telepsychiatry information increased compared to previous years, especially during the start of the COVID-19 pandemic. There may also be a higher interest in telepsychiatry among high-income nations compared to low and middle-income countries. Furthermore, the study also supports that digital information should be tailored to respond to public needs and expectations by incorporating telepsychiatry-related concepts, jobs, services, costs, and locations.
Collapse
Affiliation(s)
- Rowalt Alibudbud
- Department of Sociology and Behavioral Sciences, De La Salle University, Manila City, Philippines
| |
Collapse
|
40
|
Layton SS, Polancich S, Schexnayder J, Noot RV, Bogie K, Patrician P. Cutaneous Manifestations of COVID-19: A Descriptive Analysis of a Southeastern USA Purposive Sample. Int Wound J 2025; 22:e70193. [PMID: 40159452 PMCID: PMC11955278 DOI: 10.1111/iwj.70193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2024] [Revised: 12/31/2024] [Accepted: 01/03/2025] [Indexed: 04/02/2025] Open
Abstract
This study describes characteristics and factors associated with cutaneous manifestations of COVID-19 encountered across acute inpatient, and critical care units in a large Southeastern USA public hospital from March 1, 2020, through November 01, 2021. A retrospective descriptive analysis was conducted on a purposive sample of patients consulted for non-pressure injury related cutaneous wounds while positive for COVID-19. Patients were predominantly male (64.3%, n = 27), White (66.7%, n = 28) and Black (33.3%). No cutaneous wounds while positive for COVID-19 were observed for Hispanic patients. Patient mortality was 71.4% (n = 30). Gender distribution was proportionate by gender (67% were male) and race (65.5% were White) for deceased patients. Body mass index (BMI) ranged from 15.8 to 61.2 with a mean of 31.9 (SD = 10.76) and median BMI 28.7. Identification of cutaneous manifestations of COVID-19 and understanding of the retiform purpura pathophysiology could prove useful in guiding COVID-19 treatment regimens. Investigation into factors preventing complement cascading in those of Hispanic ethnicity may be useful in the prevention of CMC-19 and progression of severity of illness.
Collapse
Affiliation(s)
- Shannon S. Layton
- School of NursingUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Shea Polancich
- School of NursingUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Julie Schexnayder
- School of NursingUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Ross Vander Noot
- School of MedicineUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| | - Kath Bogie
- Department of OrthopaedicsCase Western Reserve UniversityClevelandOhioUSA
- Research Career Scientist, Louis Stokes Cleveland VA Medical CenterClevelandOhioUSA
| | - Patricia Patrician
- School of NursingUniversity of Alabama at BirminghamBirminghamAlabamaUSA
| |
Collapse
|
41
|
Shamim L, Musharaf I, Nashwan AJ. Dexamethasone in coronavirus disease 2019 care: Dosage and utilization insights. World J Virol 2025; 14:98765. [PMID: 40134846 PMCID: PMC11612875 DOI: 10.5501/wjv.v14.i1.98765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/04/2024] [Revised: 11/04/2024] [Accepted: 11/19/2024] [Indexed: 11/28/2024] Open
Abstract
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2. It was declared a global pandemic on March 11, 2020, by the World Health Organization. An excessive inflammatory response is a severe respiratory manifestation of COVID-19, which becomes predominant in later stages. Due to its immunosuppressive and anti-inflammatory properties, dexamethasone is the first systemic glucocorticoid to treat severe COVID-19 patients. This editorial reviews the efficacy and safety of high-dose vs low-dose dexamethasone in patients with COVID-19. Findings indicate that using low-dose dexamethasone is beneficial and emphasize the need for additional research on the use of high-dose dexamethasone. While the study provides a robust evidence base, it is limited by the lack of long-term data, focus on specific outcomes and heterogeneity of the included studies. Future research should focus on the long-term effects of dexamethasone and its impact across varying disease severities and patient populations to refine treatment strategies and improve patient care.
Collapse
Affiliation(s)
- Laiba Shamim
- Department of Clinical Medicine, Jinnah Sindh Medical University, Karachi 75510, Sindh, Pakistan
| | - Imshaal Musharaf
- Department of Medicine, Jinnah Sindh Medical University, Karachi 75510, Sindh, Pakistan
| | - Abdulqadir J Nashwan
- Department of Nursing and Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar
| |
Collapse
|
42
|
Murray A, Conroy I, Kirrane F, Cullen L, Worlikar H, O'Keeffe DT. User Experience of a Bespoke Videoconferencing System for Web-Based Family Visitation for Patients in an Intensive Care Unit: 1-Year Cross-Sectional Survey of Nursing Staff. JMIR Hum Factors 2025; 12:e54560. [PMID: 40116766 PMCID: PMC11951810 DOI: 10.2196/54560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 07/31/2024] [Accepted: 08/12/2024] [Indexed: 03/23/2025] Open
Abstract
Background During the COVID-19 pandemic, in-person visitation within hospitals was restricted and sometimes eliminated to reduce the risk of transmission of SARS-CoV-2. Many health care professionals created novel strategies that were deployed to maintain a patient-centered approach. Although pandemic-related restrictions have eased, these systems, including videoconferencing or web-based bedside visits, remain relevant for visitors who cannot be present due to other reasons (lack of access to transport, socioeconomic restraints, geographical distance, etc). Objective The aims of this study were (1) to report the experience of intensive care nursing staff using a bespoke videoconferencing system called ICU FamilyLink; (2) to examine the scenarios in which the nursing staff used the system; and (3) to assess the future use of videoconferencing systems to enhance communication with families. Methods A modified Telehealth Usability questionnaire was administered to the nursing staff (N=22) of an intensive care unit in a model 4 tertiary hospital in Ireland 1 year after implementing the bespoke videoconferencing system. Results In total, 22 nurses working in the intensive care department at University Hospital Galway, Ireland, responded to the survey. A total of 23% (n=5) of participants were between the ages of 25 and 34 years, 54% (n=12) were between 35 and 44 years, and 23% (n=5) were between 45 and 54 years. Most (n=15, 68%) of the participants reported never using videoconferencing in the intensive care setting to communicate with family members before March 2020. The modified Telehealth Usability Questionnaire showed overall satisfaction scores for each subcategory of ease of use and learnability, interface quality, interaction quality, reliability, satisfaction and future use, and usefulness. In total, 21 (95%) participants agreed or strongly agreed with the statement, "I would use the ICU FamilyLink system in future circumstances in which family members cannot be physically present (ie, pandemics, abroad, inability to travel, etc)," and 1 participant responded neutrally. One participant highlighted a common scenario in intensive care settings in which a videoconferencing system can be used "Even without COVID, web-based communication is important when patients become unexpectedly ill and when families are abroad." Conclusions This study provides valuable insights into health care professionals' experience using a videoconferencing system to facilitate web-based visits for families. We conclude that videoconferencing systems when appropriately tailored to the environment with the users in mind can be an acceptable solution to maintain communication with family members who cannot be physically present at the bedside. The bespoke videoconferencing system had an overall positive response from 22 nursing staff who interacted with the system at varying frequency levels.
Collapse
Affiliation(s)
- Aoife Murray
- Health Innovation Via Engineering Laboratory, School of Medicine, University of Galway, University Road, Galway, H91TK33, Ireland, 353 091492147
- School of Medicine, College of Medicine Nursing and Health Sciences, University of GalwayGalway, Ireland
| | - Irial Conroy
- Health Innovation Via Engineering Laboratory, School of Medicine, University of Galway, University Road, Galway, H91TK33, Ireland, 353 091492147
| | - Frank Kirrane
- Department of Medical Physics and Clinical Engineering, University Hospital Galway, Galway, Ireland
| | - Leonie Cullen
- Critical Care Department, University Hospital Galway, Galway, Ireland
| | - Hemendra Worlikar
- Health Innovation Via Engineering Laboratory, School of Medicine, University of Galway, University Road, Galway, H91TK33, Ireland, 353 091492147
| | - Derek T O'Keeffe
- School of Medicine, College of Medicine Nursing and Health Sciences, University of GalwayGalway, Ireland
- Lero Science Foundation Ireland Centre for Software Research, University of Galway, Galway, Ireland
| |
Collapse
|
43
|
Salazar AP, Lecours S, Engel L, Gignac MAM, Rotenberg S, Zarshenas S, McDonald M, Nalder E, Bottari C. Responding to the ongoing pandemic-related challenges of individuals with brain injury through the perspective of community-service in Canada: A qualitative study. Brain Inj 2025; 39:267-276. [PMID: 39550618 DOI: 10.1080/02699052.2024.2426683] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2023] [Revised: 10/30/2024] [Accepted: 11/02/2024] [Indexed: 11/18/2024]
Abstract
OBJECTIVE To investigate brain injury (BI) associations' perspectives regarding the impacts of the second year of the COVID-19 pandemic on individuals with BI and BI associations services across Canada. METHODS This qualitative descriptive study included 26 representatives of Canadian BI associations that participated in six online focus groups to discuss the effects of the second year of the pandemic on clients living with BI and on the provision of community services. RESULTS Findings revealed three main themes: 1) ongoing pandemic-related challenges faced by clients living with BI, including worsening mental health and basic needs insecurities, difficulties faced by clients in adhering to safety measures, and ongoing technological issues; 2) ongoing adaptations to accommodate clients' needs, including offering tailored services, ensuring consistent and transparent safety measures, and providing hybrid services; and 3) developing a sustainable 'new normal' aligned with association mandates and resources by expanding networks and building resilience. CONCLUSION The unfolding of the pandemic has brought increased challenges for people with BI and reinforced the need for adapted, clear, and accessible public health information to ensure the safety of vulnerable populations in times of crisis. It is essential to bolster community-based associations that provide direct care to people with BI.
Collapse
Affiliation(s)
- Ana Paula Salazar
- School of Rehabilitation, Université de Montréal, Montréal, Quebec, Canada
- Centre for Interdisciplinary Research in Rehabilitation of Greater Montréal (CRIR), Institut universitaire sur la réadaptation en déficience physique de Montréal du CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Quebec, Canada
| | - Sophie Lecours
- Centre for Interdisciplinary Research in Rehabilitation of Greater Montréal (CRIR), Institut universitaire sur la réadaptation en déficience physique de Montréal du CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Quebec, Canada
| | - Lisa Engel
- Department of Occupational Therapy, College of Rehabilitation Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
- Institute for Work & Health, Toronto, Ontario, Canada
| | - Monique A M Gignac
- Institute for Work & Health, Toronto, Ontario, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Shlomit Rotenberg
- Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Canada
| | - Sareh Zarshenas
- Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | | | - Emily Nalder
- Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Canada
| | - Carolina Bottari
- School of Rehabilitation, Université de Montréal, Montréal, Quebec, Canada
- Centre for Interdisciplinary Research in Rehabilitation of Greater Montréal (CRIR), Institut universitaire sur la réadaptation en déficience physique de Montréal du CIUSSS du Centre-Sud-de-l'Île-de-Montréal, Montréal, Quebec, Canada
| |
Collapse
|
44
|
Wong YC, Ng CJ, Huang YB, Chen SY. Effectiveness and Safety of Remdesivir for the Treatment of COVID-19 Patients with Liver Cirrhosis: A Retrospective Cohort Study. Life (Basel) 2025; 15:512. [PMID: 40283067 PMCID: PMC12028772 DOI: 10.3390/life15040512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2025] [Revised: 03/16/2025] [Accepted: 03/19/2025] [Indexed: 04/29/2025] Open
Abstract
BACKGROUND Patients with liver cirrhosis are at an increased risk of mortality from coronavirus disease 2019 (COVID-19). Remdesivir, an adenosine analog, exhibits activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is thus recommended for inpatients with COVID-19. This study evaluated the effectiveness and safety of remdesivir in patients with COVID-19 and liver cirrhosis. METHODS This retrospective study was conducted using data from Taiwan's largest healthcare system. The study cohort comprised adult patients with COVID-19 and liver cirrhosis who visited our emergency department between April 2021 and September 2022. Remdesivir's adverse effects, including bradycardia, anemia, unstable glucose levels, and abnormal liver function test results, were recorded. Treatment outcomes were assessed in terms of hospitalization duration, mortality, intubation, and intensive care unit admission. RESULTS This study included 1368 patients with COVID-19 and liver cirrhosis, of whom 46 received remdesivir. Remdesivir recipients were older (66.5 vs. 62 years; p = 0.042) and had a higher rate of oxygen therapy use (56.52% vs. 32.22%; p = 0.001) than nonrecipients. Common adverse effects of remdesivir included lower heart rates (83 vs. 96 bpm; p < 0.001) and decreased hemoglobin levels (9.5 vs. 10.2 g/dL; p = 0.003) without fatal consequences. No statistically significant difference between remdesivir recipients and nonrecipients in hospitalization duration, intubation rates, or mortality rates was found. CONCLUSIONS Remdesivir is safe for treating COVID-19 in patients with liver cirrhosis. Although remdesivir recipients exhibited trends toward improved outcomes in our study, large-scale studies are required to confirm its efficacy in this population.
Collapse
Affiliation(s)
- Yi-Ching Wong
- Department of Emergency Medicine, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; (Y.-C.W.); (C.-J.N.); (Y.-B.H.)
| | - Chip-Jin Ng
- Department of Emergency Medicine, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; (Y.-C.W.); (C.-J.N.); (Y.-B.H.)
| | - Yan-Bo Huang
- Department of Emergency Medicine, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; (Y.-C.W.); (C.-J.N.); (Y.-B.H.)
| | - Shou-Yen Chen
- Department of Emergency Medicine, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan; (Y.-C.W.); (C.-J.N.); (Y.-B.H.)
- Graduate Institute of Management, College of Management, Chang Gung University, Taoyuan 333, Taiwan
| |
Collapse
|
45
|
Gomillia CE, Arnold T, Dobbs TE, Monger ML, Nunn A, Ward LM. Access and Utilization of HIV/STI Testing Services among Men Who have Sex with Men During the COVID-19 Pandemic: A Systematic Review. J Racial Ethn Health Disparities 2025:10.1007/s40615-024-02103-z. [PMID: 40102349 DOI: 10.1007/s40615-024-02103-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Revised: 06/26/2024] [Accepted: 07/21/2024] [Indexed: 03/20/2025]
Abstract
BACKGROUND Men who have sex with men (MSM) continue to bear the disproportionate burden of HIV and other sexually transmitted infections (STIs). The public health response to the COVID-19 pandemic coupled with the public's fear of the virus may have exacerbated this burden by hindering access to and utilization of HIV/STI testing services. METHODS We completed a systematic literature review to evaluate the impact of the COVID-19 pandemic on MSM's access and utilization of HIV/STI testing services. Online databases (PubMed, EMBASE, LGBTQ + Source, CINAHL, and the WHO COVID database) and reference lists were searched until October 8, 2023 to identify literature meeting the following criteria: primary data collection; peer-reviewed publication in the English language; included MSM ≥ 18 years of age; examined access to and utilization of HIV and/or STI testing in the United States. RESULTS We identified 1,013 articles, of which 88 were eligible for full text review. Nineteen articles met full inclusion criteria and were included in the qualitative synthesis. Twelve were cross-sectional studies, 4 were prospective cohort studies, and 3 were retrospective chart reviews. Sixteen of the 19 studies reported perceived interruptions or decreases in HIV/STI testing among MSM during the COVID-19 pandemic. However, two cross-sectional studies reported increases in STI prevalence during the pandemic and one cross-sectional study reported that access to HIV testing was unaffected. CONCLUSION This systematic review summarized the existing literature that suggests that the COVID-19 pandemic largely impacted access to and utilization of HIV/STI testing among MSM in the U.S.
Collapse
Affiliation(s)
- Courtney E Gomillia
- Department of Population Health Science, University of Mississippi Medical Center, 2500 N State Street, TR202, Jackson, MS, 39216, USA.
| | - Trisha Arnold
- Department of Psychiatry, Rhode Island Hospital, Providence, Rhode Island, USA
- Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
| | - Thomas E Dobbs
- Department of Population Health Science, University of Mississippi Medical Center, 2500 N State Street, TR202, Jackson, MS, 39216, USA
| | - Mauda L Monger
- Department of Population Health Science, University of Mississippi Medical Center, 2500 N State Street, TR202, Jackson, MS, 39216, USA
| | - Amy Nunn
- Department of Medicine, Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA
- Department of Social and Behavioral Sciences, Brown University School of Public Health, Providence, Rhode Island, USA
| | - Lori M Ward
- Department of Population Health Science, University of Mississippi Medical Center, 2500 N State Street, TR202, Jackson, MS, 39216, USA
| |
Collapse
|
46
|
Estadilla CDS, Cicolani C, Blasco-Aguado R, Saldaña F, Borri A, Mar J, Van-Dierdonck JB, Ibarrondo O, Stollenwerk N, Aguiar M. The impact of non-pharmaceutical interventions on COVID-19 transmission and its effect on life expectancy in two European regions. BMC Public Health 2025; 25:1004. [PMID: 40087626 PMCID: PMC11907853 DOI: 10.1186/s12889-025-22239-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Accepted: 03/07/2025] [Indexed: 03/17/2025] Open
Abstract
BACKGROUND In response to the rapid global transmission of COVID-19, governments worldwide enacted lockdowns and other non-pharmaceutical interventions (NPI) to control the disease. In this study, we aim to quantify the influence of NPIs on the transmission of COVID-19 within selected European regions, specifically Spain (including the Basque Country) and Italy (including Tuscany), during the period of February to December 2020, which predates the initiation of COVID-19 vaccinations. We investigate potential correlations and associations between the implementation of NPIs, changes in COVID-19 transmission rates, and alterations in life expectancy across different age and sex categories from the year 2019 to 2020. METHODS We use a Susceptible-Hospitalized-Asymptomatic/Mild-Recovered-Deceased (SHARD) ordinary differential equations model to analyze COVID-19 dynamics in the studied regions. The model calibration process was performed with empirical data on hospitalization and death to estimate the weekly transmission and death rates. To quantify reductions in life expectancy, we used established survival analysis techniques. RESULTS The SHARD model effectively captures multiple waves of COVID-19, accurately representing peaks and aligning with the instantaneous reproduction number. Our analysis reveals a 66-78% reduction in transmission rates during the initial set of NPIs in March 2020, followed by a 34-55% reduction during the subsequent NPIs in October 2020. Additionally, the elderly and individuals with comorbidities experienced the most pronounced reductions in life expectancy. CONCLUSIONS Our model calibration approach provides a valuable tool for evaluating the effectiveness of interventions across multiple waves of an epidemic. By applying this method to COVID-19 dynamics, we have demonstrated the capacity to quantify the impact of non-pharmaceutical interventions (NPIs) on transmission rates. These findings offer practical insights into the effectiveness of NPIs in mitigating COVID-19 spread and contribute to the broader understanding of epidemic control strategies.
Collapse
Affiliation(s)
- Carlo Delfin S Estadilla
- BCAM-Basque Center for Applied Mathematics, Bilbao, Basque Country, Spain
- Preventive Medicine and Public Health Department, University of the Basque Country (UPV/EHU), Leioa, Basque Country, Spain
| | - Chiara Cicolani
- BCAM-Basque Center for Applied Mathematics, Bilbao, Basque Country, Spain
- Università degli studi dell'Aquila, L'Aquila, Italy
| | | | - Fernando Saldaña
- BCAM-Basque Center for Applied Mathematics, Bilbao, Basque Country, Spain
| | - Alessandro Borri
- Università degli studi dell'Aquila, L'Aquila, Italy
- IASI-Institute for System Analysis and Computer Science, Rome, Italy
| | - Javier Mar
- Osakidetza Basque Health Service, Arrasate-Mondragón, Basque Country, Spain
- Biodonostia Health Research Institute, Donostia-San Sebastián, Basque Country, Spain
| | | | - Oliver Ibarrondo
- Osakidetza Basque Health Service, Arrasate-Mondragón, Basque Country, Spain
| | - Nico Stollenwerk
- BCAM-Basque Center for Applied Mathematics, Bilbao, Basque Country, Spain
| | - Maíra Aguiar
- BCAM-Basque Center for Applied Mathematics, Bilbao, Basque Country, Spain.
- Ikerbasque, Basque Foundation for Science, Bilbao, Basque Country, Spain.
| |
Collapse
|
47
|
Sculco C, Bano B, Prina E, Tedeschi F, Bartucz MB, Barbui C, Purgato M, Albanese E. Access and use of general and mental health services before and during the COVID-19 pandemic: a systematic review and meta-analysis. BMJ Open 2025; 15:e091342. [PMID: 40074252 PMCID: PMC11904334 DOI: 10.1136/bmjopen-2024-091342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/18/2024] [Accepted: 02/10/2025] [Indexed: 03/14/2025] Open
Abstract
OBJECTIVES To quantify access to health services during the COVID-19 pandemic and measure the change in use between the prepandemic and the pandemic periods in a population with assessment of psychological distress or diagnosis of mental disorders. DATA SOURCES We developed and piloted a search syntax and adapted it to enter the following databases from 1 January 2020 to 31 March 2023: PubMed/MEDLINE, PsycINFO, Web of Science, Epistemonikos and the WHO International Clinical Trials Registry Platform. We reran the searches from the end of the original search to 3 December 2024. DESIGN We systematically screened titles, abstracts and full texts of retrieved records. ELIGIBILITY CRITERIA We included observational studies on any populations and regions, covering health services such as doctor visits, hospital admissions, diagnostic examinations, pharmaceutical therapies and mental health (MH) services. Only studies using validated scales to assess psychological distress or mental disorders as defined in the Diagnostic and Statistical Manual of Mental Disorders were included. DATA EXTRACTION AND SYNTHESIS We extracted data using a purposefully designed form and evaluated the studies' quality with the Newcastle-Ottawa Scale. We measured the incidence rate (IR) of access to health services and the IR ratio (IRR) between the prepandemic and the pandemic periods. We calculated contacts days and catchment areas in the different periods. We used the random effects DerSimonian-Laird inverse-variance model and calculated heterogeneity with statistics I² and τ². We computed pooled IR and pooled IRR and tested the hypothesis of no variation (IRR=1). RESULTS We retrieved 10 014 records and examined the full text of 580 articles. We included 136 primary studies of which 44 were meta-analysed. The IR of access to services during the pandemic was 2.59 contact months per 10 000 inhabitants (IR=2.592; 95% CI: 1.301 to 5.164). We observed a reduction of 28.5% in the use of services with negligible differences by age group and type of services (IRR=0.715; 95% CI: 0.651 to 0.785). We observed significant differences in effect sizes across studies (τ2=5.44; p<0.001 and τ2=0.090; p<0.001). CONCLUSION By considering MH, our study provides consolidated evidence and quantifies the reduction in the use of health services during the COVID-19 pandemic. PROSPERO REGISTRATION NUMBER CRD42023403778.
Collapse
Affiliation(s)
- Camilla Sculco
- Institute of Public Health, Universita della Svizzera italiana, Lugano, Ticino, Switzerland
| | - Beatrice Bano
- Institute of Public Health, Universita della Svizzera italiana, Lugano, Ticino, Switzerland
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
| | - Eleonora Prina
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
| | - Federico Tedeschi
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Cochrane Global Mental Health, University of Verona, Verona, Italy
| | - Monica Bianca Bartucz
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
| | - Corrado Barbui
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Cochrane Global Mental Health, University of Verona, Verona, Italy
| | - Marianna Purgato
- Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy
- Cochrane Global Mental Health, University of Verona, Verona, Italy
| | - Emiliano Albanese
- Institute of Public Health, Universita della Svizzera italiana, Lugano, Ticino, Switzerland
| |
Collapse
|
48
|
Yoo J, Seo JW, Ock M, Jun JY. Screening and monitoring patients at high risk for mental health issues in COVID-19: a multicenter pre-post assessment study. BMC Psychol 2025; 13:226. [PMID: 40069877 PMCID: PMC11895362 DOI: 10.1186/s40359-025-02514-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Accepted: 02/20/2025] [Indexed: 03/15/2025] Open
Abstract
PURPOSE This study aimed to present the methods for screening, monitoring, and intervening with patients at high risk for mental health issues with COVID-19 at residential treatment centers, which are isolation treatment facilities for COVID-19 patients. METHODS We evaluated the mental health status of COVID-19 patients in three residential treatment centers. At admission and one day before discharge, patients received via their mobile a questionnaire containing one question each on anxiety, subjective psychological distress, post-traumatic stress symptoms, depression and suicidal ideation to identify those at high risk for mental health issues. High-risk patients and normal-risk participants who requested consultation were referred for psychological counseling. We evaluated the participants' clinical and mental health characteristics and performed a logistic regression analysis to identify factors associated with worsened depression and suicide risk at discharge. RESULTS Of 5,163 qualifying patients, 1,941 patients (37.6%) had their mental health assessed both at admission and discharge. In total, 661 persons (34.1%) required mental health support at admission and 648 persons (33.4%) at discharge. The patients at high risk for mental health issues at admission had an odds ratio of 5.31 (95% CI: 4.23-6.66) for depression at discharge, compared to those with normal mental health status at admission. The group that requested professional psychological counseling at admission showed an odds ratio of 2.33 (95% CI: 1.31-4.13) for depression at discharge. CONCLUSIONS Repeated mental health monitoring is crucial for COVID-19 patients. Additionally, a flexible intervention strategy should be developed to implement different screening methods for patients at high risk for mental health issues, depending on the status of the COVID-19 epidemic and available resources.
Collapse
Affiliation(s)
- Jeonga Yoo
- Ulsan Center for Infectious Disease Control & Prevention, Ulsan, Republic of Korea
| | - Jeong-Wook Seo
- Public Health and Medical Services Team, Ulsan University Hospital, Ulsan, Republic of Korea
| | - Minsu Ock
- Task Forces to Support Public Health and Medical Services in Ulsan Metropolitan City, Ulsan, Republic of Korea.
- Department of Preventive Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
- Department of Preventive Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Ulsan University Hospital, University of Ulsan College of Medicine, Daehagbyeongwon-ro 25, Dong-gu, Ulsan, 44033, Republic of Korea.
| | - Jin Yong Jun
- Department of Psychiatry, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
- Ulsan University Hospital, University of Ulsan College of Medicine, Daehagbyeongwon-ro 25, Dong-gu, Ulsan, 44033, Republic of Korea.
| |
Collapse
|
49
|
Vadi S, Sanwalka N, Thaker P. Healthcare providers’ perspectives on factors influencing their critical care decision-making during the COVID-19 pandemic: An international pilot survey. World J Crit Care Med 2025; 14:97006. [DOI: 10.5492/wjccm.v14.i1.97006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 10/24/2024] [Accepted: 11/19/2024] [Indexed: 12/11/2024] Open
Abstract
BACKGROUND Understanding a patient's clinical status and setting priorities for their care are two aspects of the constantly changing process of clinical decision-making. One analytical technique that can be helpful in uncertain situations is clinical judgment. Clinicians must deal with contradictory information, lack of time to make decisions, and long-term factors when emergencies occur.
AIM To examine the ethical issues healthcare professionals faced during the coronavirus disease 2019 (COVID-19) pandemic and the factors affecting clinical decision-making.
METHODS This pilot study, which means it was a preliminary investigation to gather information and test the feasibility of a larger investigation was conducted over 6 months and we invited responses from clinicians worldwide who managed patients with COVID-19. The survey focused on topics related to their professional roles and personal relationships. We examined five core areas influencing critical care decision-making: Patients' personal factors, family-related factors, informed consent, communication and media, and hospital administrative policies on clinical decision-making. The collected data were analyzed using the χ2 test for categorical variables.
RESULTS A total of 102 clinicians from 23 specialties and 17 countries responded to the survey. Age was a significant factor in treatment planning (n = 88) and ventilator access (n = 78). Sex had no bearing on how decisions were made. Most doctors reported maintaining patient confidentiality regarding privacy and informed consent. Approximately 50% of clinicians reported a moderate influence of clinical work, with many citing it as one of the most important factors affecting their health and relationships. Clinicians from developing countries had a significantly higher score for considering a patient's financial status when creating a treatment plan than their counterparts from developed countries. Regarding personal experiences, some respondents noted that treatment plans and preferences changed from wave to wave, and that there was a rapid turnover of studies and evidence. Hospital and government policies also played a role in critical decision-making. Rather than assessing the appropriateness of treatment, some doctors observed that hospital policies regarding medications were driven by patient demand.
CONCLUSION Factors other than medical considerations frequently affect management choices. The disparity in treatment choices, became more apparent during the pandemic. We highlight the difficulties and contradictions between moral standards and the realities physicians encountered during this medical emergency. False information, large patient populations, and limited resources caused problems for clinicians. These factors impacted decision-making, which, in turn, affected patient care and healthcare staff well-being.
Collapse
Affiliation(s)
- Sonali Vadi
- Department of Critical Care Medicine, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai 400053, Mahārāshtra, India
| | - Neha Sanwalka
- Department of Statistics, HCJMRI, Jehangir Hospital, Pune 411001, Mahārāshtra, India
| | - Pramod Thaker
- Medical Ethics Fellowship, Harvard Medical School, Boston, MA 02138, United States
| |
Collapse
|
50
|
Toprak M, Kesim E, Karasu B, Celebi ARC. Choroidal vascularity ındex findings ın patients recovered from mild course COVID-19 pneumonia. Int Ophthalmol 2025; 45:84. [PMID: 40045062 DOI: 10.1007/s10792-025-03450-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2024] [Accepted: 02/03/2025] [Indexed: 05/13/2025]
Abstract
PURPOSE To assess the choroidal vascularity index (CVI) in individuals who have recovered from moderate pneumonia caused by COVID-19, using enhanced depth imaging optical coherence tomography (EDI-OCT). METHODS This study included 43 patients who had recovered from SARS-CoV-2 infection with mild pneumonia (Group 1-COVID group), as well as 45 healthy individuals (Group 2- healthy control group). The study comprised COVID-19 patients who fully recovered from COVID-19 pneumonia. These patients were assessed 6 months after their pneumonia had totally resolved. The measurements were acquired via EDI-OCT investigations of the choroidal structures. The primary measure of interest was the CVI, which is defined as the ratio of the luminal area (LA) to the total choroidal area (TCA). RESULTS Patients from Group 1 (COVID group) who had totally recovered exhibited significantly higher mean TCA, stromal area (SA), and LA compared to patients from Group 2 (control or healthy group). The two groups did not show a significant difference in CVI (p = 0.080). CONCLUSION Choroidal vascularity index can reveal the choroidal vascular physiology in patients who have fully recovered from COVID-19 pneumonia. EDI-OCT can be utilized to evaluate choroidal vascular alterations, serving as a non-invasive indicator for early vascular impairment following SARS-CoV-2 infection.
Collapse
Affiliation(s)
- Muge Toprak
- Kocaeli City Hospital, Evliya Celebi Mh. Ertas Sk. Cornercity B Block No:12, 34944, Tuzla, Istanbul, Kocaeli, Turkey.
| | - Enes Kesim
- Department of Ophthalmology, Okan University Medical School, Istanbul, Turkey
| | - Buğra Karasu
- Department of Ophthalmology, Tuzla State Hospital, Istanbul, Turkey
| | - Ali Riza Cenk Celebi
- Department of Ophthalmology, Acibadem University Medical School, Istanbul, Turkey
| |
Collapse
|